Measuring voluntary and reflexive cough strength in healthy individuals. by Mills, Claire S.
   
 
 
Measuring Voluntary and Reflexive Cough 
Strength in Healthy Individuals 
 
 
 
A thesis submitted in partial fulfilment of the requirements 
for the Degree of Master of Science in Speech and 
Language Sciences at the University of Canterbury 
 
 
 
 
 
Claire S. Mills 
I.D. 34587751 
The University of Canterbury 
2016 
  
 
 
 
 
MEASURING VOLUNTARY AND REFLEXIVE COUGH STRENGTH IN HEALTHY INDIVIDUALS  1 
 
 
 
TABLE OF CONTENTS 
LIST OF TABLES ................................................................................................................... 1 
LIST OF FIGURES ................................................................................................................. 2 
ACKNOWLEDGEMENTS .................................................................................................... 3 
ABSTRACT .............................................................................................................................. 4 
ABBREVIATIONS .................................................................................................................. 6 
 Introduction .................................................................................................................. 7 
 Literature Review ........................................................................................................ 8 
2.1 Definition of Cough ............................................................................................. 8 
2.2 Neurological Control of Cough ........................................................................... 8 
2.3 Differences between Reflexive and Voluntary Coughing ................................. 10 
2.4 Cough Reflex Testing ........................................................................................ 12 
2.5 Objective Cough Strength Testing ..................................................................... 14 
2.5.1 Cough Peak Flow ........................................................................................... 14 
2.5.2 Thermal Measures of Cough .......................................................................... 16 
2.5.3 Acoustic Measures of Cough ......................................................................... 16 
2.5.4 Electromyography of Cough .......................................................................... 17 
2.5.5 Cough Pressures ............................................................................................. 18 
2.6 Gaps in the Research .......................................................................................... 20 
2.7 Problem Statement ............................................................................................. 21 
2.8 Objective and Hypotheses.................................................................................. 21 
 Methodology ............................................................................................................... 23 
3.1 Study Design ...................................................................................................... 23 
3.2 Ethical considerations ........................................................................................ 23 
3.3 Participants ......................................................................................................... 23 
3.4 Resources ........................................................................................................... 24 
3.5 Procedure ........................................................................................................... 27 
3.6 Data Extraction .................................................................................................. 28 
3.6.1 Procedure ........................................................................................................ 28 
3.6.2 Rationale......................................................................................................... 32 
3.7 Data Analysis ..................................................................................................... 34 
 Results ......................................................................................................................... 35 
MEASURING VOLUNTARY AND REFLEXIVE COUGH STRENGTH IN HEALTHY INDIVIDUALS  2 
 
 
 
4.1 Reflexive Cough ................................................................................................ 35 
4.1.1 Pressure .......................................................................................................... 35 
4.1.2 Flow ................................................................................................................ 36 
4.1.3 Acoustic .......................................................................................................... 38 
4.2 Voluntary Coughs .............................................................................................. 39 
4.2.1 Pressure .......................................................................................................... 39 
4.2.2 Flow ................................................................................................................ 41 
4.2.3 Acoustic .......................................................................................................... 43 
4.3 Reflexive Cough versus Voluntary Cough ........................................................ 45 
4.4 Comparisons of Measures .................................................................................. 46 
4.5 Marker Placement Error ..................................................................................... 46 
 Discussion.................................................................................................................... 49 
5.1 Reflexive Cough ................................................................................................ 49 
5.2 Voluntary Cough ................................................................................................ 51 
5.3 Reflexive Cough versus Voluntary Cough ........................................................ 52 
5.4 Outcome Measures............................................................................................. 52 
5.5 Error in Marker Placements ............................................................................... 52 
5.6 Exclusions .......................................................................................................... 53 
5.7 Limitations ......................................................................................................... 54 
5.8 Clinical Implications .......................................................................................... 55 
5.9 Future Directions ............................................................................................... 55 
 Conclusion .................................................................................................................. 57 
 Reference List ............................................................................................................. 58 
APPENDICES ........................................................................................................................ 64 
 
 
 
 
 
 
MEASURING VOLUNTARY AND REFLEXIVE COUGH STRENGTH IN HEALTHY INDIVIDUALS  1 
 
 
 
LIST OF TABLES 
 
Table 1. Differences between reflexive cough 1 and 2 at citric acid dose 3 with voluntary 
cough 1 and 2 for each outcome measure ............................................................................ 45 
Table 2. Correlations between six measures for reflexive and voluntary cough. ............ 46 
Table 3. RMSE for peak pressure and AUC pressure for each of the eight coughs ........ 47 
Table 4. RMSE for peak flow and AUC flow for each of the eight coughs ...................... 48 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MEASURING VOLUNTARY AND REFLEXIVE COUGH STRENGTH IN HEALTHY INDIVIDUALS  2 
 
 
 
LIST OF FIGURES 
 
Figure 1. Set-up of spirometer flow head, spirometer pod, PowerLab and bridge 
amplifier. ................................................................................................................................. 25 
Figure 2. Littmann stethoscope attached to microphone on a neck strap. ....................... 26 
Figure 3. Face mask with tubing attached. .......................................................................... 26 
Figure 4. Full set-up of equipment. ...................................................................................... 26 
Figure 5. Automatic marker placement for two strong voluntary coughs ....................... 30 
Figure 6. Manual placement of markers for citric acid 1.8M/L ........................................ 31 
Figure 7. Manual placement of markers for two voluntary weak coughs ........................ 32 
Figure 8. Mean peak pressure for reflexive cough.............................................................. 35 
Figure 9. Mean AUC pressure for reflexive cough. ............................................................ 36 
Figure 10. Mean peak flow for reflexive cough. .................................................................. 37 
Figure 11. Mean AUC flow for reflexive cough. ................................................................. 37 
Figure 12. Mean peak acoustic for reflexive cough. ........................................................... 38 
Figure 13. Mean AUC acoustic for reflexive cough. ........................................................... 39 
Figure 14. Mean peak pressure for voluntary cough.......................................................... 40 
Figure 15.  Mean AUC pressure for voluntary cough. ....................................................... 41 
Figure 16. Mean peak flow for voluntary cough. ................................................................ 42 
Figure 17. Mean AUC flow for voluntary cough. ............................................................... 43 
Figure 18. Mean peak acoustic for voluntary cough. ......................................................... 44 
Figure 19. Mean AUC acoustic for voluntary cough. ......................................................... 44 
 
 
 
 
 
MEASURING VOLUNTARY AND REFLEXIVE COUGH STRENGTH IN HEALTHY INDIVIDUALS  3 
 
 
 
ACKNOWLEDGEMENTS 
  
I would like to express my heartfelt thanks to Professor Maggie-Lee Huckabee for the 
opportunity to undertake my Master’s Thesis under her excellent supervision. When she first 
suggested to me five years ago, on a train platform in the UK, that I travel to New Zealand to 
study under her, I thought it would never happen. Well, it did and I have learnt so much from 
her. I am extremely grateful for all her time, patience, encouragement and support.   
 I also wish to thank Professor Richard Jones for his support as my Supervisor. His 
advice, encouragement and wisdom have been truly invaluable. Huge thanks to Ester Guiu 
Hernandez. Her technical and computer expertise are exceptional and I am eternally grateful 
for all her time and assistance. I am also very grateful to Dr. Jonathan Hill and Alan Woods 
for their assistance in setting up and loaning valuable equipment.  
  Finally, I am extremely grateful to my family, particularly my father, for supporting 
me in this adventure to the other side of the world to complete this research. Dad, thank you 
for always backing me, even when you think I am doing something crazy! 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
MEASURING VOLUNTARY AND REFLEXIVE COUGH STRENGTH IN HEALTHY INDIVIDUALS  4 
 
 
 
ABSTRACT 
Introduction: Several studies have evaluated citric acid cough reflex in healthy individuals 
and neurologically impaired patients. These studies have been instrumental in providing 
evidence for its use as a validated tool in bedside swallowing evaluations, enabling the 
identification of patients at risk of silent aspiration. However, inter- and intra-rater reliability 
for perceptual measurements of strength of coughing is sub-optimal and there are no 
established objective methods for measuring strength of reflexive coughing. The aim of this 
study was to objectively evaluate voluntary and reflexive cough strength in healthy 
individuals.  
Methods: Fifty-four healthy individuals, aged 50 years and over, participated in this study. 
Participants performed ‘strong’ and ‘weak’ voluntary coughs and underwent suppressed 
cough reflex testing using the face-mask method and incremental doses of citric acid at doses 
of 0.4, 0.8, 1.2 and 1.8 Mol/L. Peak and area under the curve (AUC) measurements were 
taken for pressure, airflow, and acoustics. Twenty-nine sets of data, where participants 
produced a C2 response to three doses of citric acid, were included for final analysis.  
Results: Repeated-measures ANOVA revealed a significant trial effect for reflexive cough, 
with the second cough in the C2 sequence being smaller than the first, for all 6 measures 
(pressure: peak p < .01, AUC p < .01; flow: peak p < .01, AUC p < .01; acoustic: peak p = 
.04 and AUC p < .01). However, there was no significant effect of citric acid dose on strength 
of reflexive coughing (pressure: peak p = .65, AUC p =.86; flow: peak p = .95, AUC p = .10; 
acoustic: peak p = .93, AUC p = .93). Repeated-measures ANOVA also revealed a significant 
effect of type of voluntary cough, with strong coughs having greater values than weak coughs 
for all 6 measures (p  < .01). There was also a significant trial effect of voluntary cough in the 
C2 sequence, with the second cough being weaker than the first for 4 of the measures (p < .01 
for peak and AUC pressure; p < .01 for peak flow and AUC acoustic). Paired t-tests 
demonstrated that strong voluntary coughs were stronger than reflexive coughs for all 
measures (p <.01). 
Conclusions: This research suggests that all six outcome measures were sensitive to 
measuring changes in coughing strength. The significant difference between strong voluntary 
coughs and reflexive coughs supports existing research suggesting that assessment of 
voluntary coughing strength does not provide accurate information about the strength of the 
reflexive coughing. There was an effect of cough sequence, cough 1 or 2, for both voluntary 
and reflexive coughing. This might indicate that the first reflexive cough is the most 
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important in terms of airway protection and clearance. There was no effect of concentration 
of citric acid on strength of suppressed coughing: once the reflex was elicited, coughing 
strength was stable regardless of stimulus dose. This suggests that either cortical 
augmentation of voluntary coughing produces a response much greater than the reflexive 
airway protective response, or that cortical control cannot suppress sensitivity of coughing, 
but can suppress strength of coughing, at increasing concentrations of citric acid. 
Alternatively, it may imply that a suppressed cough reflex is an all-or-nothing response, but 
there is potential that a true reflexive cough, stimulated by aspiration, would show a dose-
response effect. 
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ABBREVIATIONS 
 
ANOVA analysis of variance 
AUC  area-under-the-curve 
C2   2 coughs without intervening inspiration, threshold response  
C5  5 coughs without intervening inspiration, supra-threshold response 
CDHB  Canterbury District Health Board 
CR  cough reflex 
CRT  cough reflex testing or cough reflex test 
EMG  electromyography 
ERS  European Respiratory Society 
FEES  Fibreoptic Endoscopic Evaluation of Swallowing 
fMRI  functional magnetic resonance imaging 
LER  laryngeal expiratory reflex 
MCA  middle cerebral artery 
NBM  Nil-by-mouth 
NC  natural cough 
RAR  rapidly adapting receptors 
RC  reflexive cough (both the LER and CR) or reflexive coughing 
SAR  slowly adapting receptors 
SC  suppressed cough 
sEMG  surface electromyography 
VC  voluntary cough or voluntary coughing 
VFSS  Videofluoroscopic Swallowing Study 
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 Introduction 
Dysphagia, or swallowing difficulties, can occur as a result of congenital impairment 
or can be acquired secondary to neurological impairment. Dysphagia can have a significant 
impact on both quality of life and safety; if food and drink are aspirated into the lungs it can 
result in aspiration pneumonia which can have serious, and even fatal, consequences. 
Coughing plays an important role in protecting the lungs from aspiration, and when impaired 
can result in disastrous consequences for the individual. Cough reflex testing in the 
neurologically impaired population, particularly the stroke population, has been shown to be 
highly effective in identifying people with impaired cough sensitivity, who are at risk of 
silent aspiration (aspiration without coughing) and developing pneumonia (Miles, Moore, et 
al., 2013). As yet, there is no established method of objectively assessing strength of reflexive 
coughing which is vital to provide a more specific and objective measure of risk of aspiration 
pneumonia.  
This thesis investigates the objective measurement of strength of suppressed reflexive 
coughing in healthy individuals and compares this to strength of voluntary coughing. 
Outcome measures included peak and area under the curve (AUC) for pressure, airflow and 
acoustics. Reflexive coughing was assessed using the face-mask method with nebulized citric 
acid at doses of 0.4, 0.8, 1.2 and 1.8 Mol/L. The information gained from this study will 
enhance the evidence-base concerning the differences between reflexive and voluntary cough 
and explore, for the first time, strength of suppressed reflexive coughing. It will also 
contribute to the development of a clinically practical approach for objective measurement of 
strength of reflexive coughing and the establishment of a reflexive coughing strength 
threshold.  
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 Literature Review 
2.1  Definition of Cough 
Coughing is the body’s mechanism for airway protection, and facilitates the removal 
of both inhaled particulates and secretions from the lungs (Haji, Kimura, & Ohi, 2013). It is a 
three-stage motor process which consists of an inspiratory phase, a compressive phase which 
involves high velocity expiratory airflow against a closed glottis, and an expulsive phase 
where the glottis opens and there is rapid and forceful expiration with the distinctive cough 
sound (Morice et al., 2007). A cough rarely takes place in isolation but typically occurs in a 
sequence of coughing events or components (Paul, Wai, Jewell, Shaffer, & Varadan, 2006). 
A cough can be voluntary or involuntary, and it is the involuntary reflexive cough that 
specifically act to protect the airway from any inhaled particulates, for example, food and 
drink aspirated into the lungs (Smith Hammond et al., 2001). 
Dystussia is defined as a disordered cough response (Pitts et al., 2014). Coughing can 
be impaired in different ways. For example, sensitivity of coughing can be disrupted, 
resulting in reduced or absent response to saliva, food or drink passing the level of the vocal 
cords into the airway, termed silent aspiration. Coughing strength can also be impaired 
resulting in a reduced ability to prevent material from entering the airway, or expectorate any 
aspirated material from the airway (Bianchi, Baiardi, Khirani, & Cantarella, 2012). Both 
impaired strength and sensitivity of coughing have been shown to be associated with 
increased risk of aspiration and pneumonia (Miles, Moore, et al., 2013; Smith Hammond et 
al., 2009). 
2.2 Neurological Control of Cough 
Voluntary coughing (VC) is mediated by the cerebral cortex as it involves intentional 
control (Widdicombe, Addington, Fontana, & Stephens, 2011). Cortical regions activated 
during VC include the supplementary motor cortex, primary motor cortex, sensorimotor 
cortex, somatosensory cortex, and the midbrain-pons region (Simonyan, Saad, Loucks, 
Poletto, & Ludlow, 2007). In contrast, reflexive coughing (RC) is controlled primarily by the 
brainstem and is triggered when a threshold of stimulation is reached in the sensory nerve 
fibres in the upper airway, larynx, trachea, bronchi, and the lower airway. There are three 
types of nerve fibres involved in the cough reflex: the slowly adapting stretch receptors 
(SARs), the nociceptive receptors (C-fibres), and the rapidly adapting receptors (RARs) (Haji 
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et al., 2013). The SARs are mechanosensors, the C-fibres are chemosensors, and the RARs 
are mechanosensors stimulated by both mechanical and chemical stimuli. SARs have been 
found to inhibit respiration and it has been suggested that they regulate the cough reflex 
rather than directly elicit it (Mazzone, 2004). C-fibres are more numerous than RARs or 
SARs, and are found both in the intrapulmonary and extrapulmonary airway epithelium. C-
fibres are believed to be involved in the elicitation of the RC, but it has also been postulated 
that they are involved in regulation and inhibition of coughing (Canning, 2006). RARs 
respond and adapt quickly to any physiological changes in the intrapulmonary and 
extrapulmonary airways, for example changes in lung inflation or deflation. RARs have only 
been found to respond to one tussigenic agent, citric acid (Pecova, Javorkova, Kudlicka, & 
Tatar, 2007). It is believed that RARs are directly activated by the low pH of citric acid 
resulting in mechanical distortion of the nerve ending (Kollarik & Undem, 2002; Mazzone, 
2005). Indirect activation of  RARs also occurs via the bronchoconstriction effects of citric 
acid (Mazzone, 2005). It is still unclear which of these three receptors, individually or 
collectively, are responsible for the elicitation of the RC and precisely how they work 
together to regulate it (Canning, 2006; Haji et al., 2013). 
Mazzone, Cole, Ando, Egan, & Farrell (2011) investigated neurological control of 
VC, non-evoked suppressed coughing (where participants were instructed not to cough and 
coughing was completely suppressed) and evoked cough reflex (where participants were 
instructed to cough whilst breathing in capsaicin) in healthy individuals undergoing fMRI. 
They found that during VC and non-evoked suppressed cough the primary motor and 
somatosensory cortices and the posterior mid-cingulate cortex are activated. Non-evoked 
suppressed cough produced activation of the pre-supplementary motor area and the caudate. 
Conversely, evoked RC resulted in activation of the rostral and caudal medulla. These 
findings support previous research that VC and non-evoked suppressed coughing are 
cortically controlled and RC is mediated by the brainstem. It would have been useful if they 
had also included fMRI of evoked suppressed coughing, when suppression of true RC was no 
longer possible. This would have provided information regarding differences in the 
neurological control of evoked suppressed coughing and RC. 
It has been suggested that the amygdalo-hypothalamo-reticular pathway and 
supratentorial connections act to modulate brainstem control of the cough reflex, as 
disruption of these regions following cerebral infarcts can result in dystussia (Addington, 
Stephens, Widdicombe, & Rekab, 2005). It has also been hypothesized that voluntary 
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suppression of coughing is mediated by the pyramidal tracts and that any impairment to these 
tracts could result in a lower suppressed cough reflex threshold (Smith & Wiles, 1998). 
2.3 Differences between Reflexive and Voluntary Coughing  
A cough reflex (CR) is similar to a VC, in that it is also composed of an inspiratory 
phase, a compressive phase and an expulsive phase, however it is triggered by sensory 
stimulation and is brainstem mediated. A laryngeal expiration reflex (LER), is different to a 
CR in that it is composed of a two phase response: the compressive phase and the expulsive 
phase (Tatar, Hanacek, & Widdicombe, 2008). This lack of inspiratory phase in a LER is an 
airway protective mechanism which prevents inhalation of the aspirate into the airway 
(Widdicombe et al., 2011). Conversely, the inclusion of the inspiratory phase in a CR enables 
a greater strength for the expulsive phase of the cough to enable more effective clearance of 
the airway and lungs (Tatar et al., 2008). Vovk et al. (2007) reported that LERs are typically 
weaker and of shorter duration than CRs, which they postulated is due to a lack of an 
inspiratory phase. 
Reflexive coughs usually appear in a sequence rather than in isolation. When a cough 
sequence is reflexively triggered, it is usually composed of a mixture of CRs and LERs 
(Stephens, Addington, & Widdicombe, 2003; Widdicombe & Fontana, 2006). It is difficult to 
distinguish a CR from an LER in a cough sequence without physiological measures, such as 
airflow or pressure. Research has found that with increasing strength of tussigenic agent there 
is increased number of both CRs and LERs (Vovk et al., 2007). They also found that there 
were fewer LERs than CRs elicited at every concentration of capsaicin. Indeed, 92% of 
coughs were identified as CRs and only 8% were LERs (Vovk et al., 2007). Given that 
tussigenic agents usually stimulate the elicitation of a mix of CRs and LERs, when the term 
‘cough reflex’ or ‘reflexive cough’ is used it is typically signifying both CRs and LERs 
(Tatar et al., 2008). Both the LER and the RC are of interest in the dysphagic population, as a 
person’s ability to reflexively prevent entry into the airway and clear any aspirated material is 
important for pulmonary safety. For these reasons, when the term RC is used, it refers to the 
mixture of CRs and LERs that are elicited by sensory stimulation. 
Lasserson et al. (2006) compared VC and RC strength in healthy individuals, using 
surface electromyography (sEMG) of expiratory and accessory muscles, as well as airflow 
measures. They found the respiratory muscles are activated simultaneously and quickly in 
RC, whereas muscles are activated sequentially and more slowly in VC. They also discovered 
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that cough flow rate is greater for VC than for RC. They reported that these differences 
enable optimum airway protection and clearance in RC and enhanced control and modulation 
of VC (Lasserson et al., 2006).  
Historically, assessment of the cortically-controlled VC has been used to provide 
information about a person’s ability to clear and protect their airway (Smina et al., 2003; 
Smith Hammond et al., 2009). Indeed, some research has suggested that there is good 
correlation between strength of VC and risk of aspiration (Smith Hammond et al., 2001). 
However, Smith Hammond et al. (2001) also reported that there is a lack of specificity in the 
findings for an individual’s relative risk of aspiration. General consensus is now shifting 
towards the importance of assessing RC, rather than VC, to make judgements about an 
individual’s ability to protect and clear their airway, as this is believed to be more accurate in 
identifying risk of pneumonia, particularly with regard to involuntary response to aspiration 
(Addington, Stephens, Phelipa, Widdicombe, & Ockey, 2008; Magni, Chellini, Lavorini, 
Fontana, & Widdicombe, 2011; Widdicombe et al., 2011). 
Both VC and RC can be impaired in similar ways. For example, damage to the vagus 
or glossopharyngeal nerves can result in desensitisation of the mucosa of the pharynx, larynx 
and trachea. Desensitisation can also occur secondary to intubation trauma or following 
increased pooling of secretions in the larynx (Smith & Wiles, 1998). This altered sensation in 
the upper airway can result in reduced sensitivity of reflexive coughing and reduced urge-to-
cough with consequent impaired VC (Widdicombe & Singh, 2006). Patients who have 
disordered neurological control of respiration have been found to have more variable cough 
compression times than healthy controls, which results in more inconsistent subglottic 
pressure build up prior to the expiratory phase. This erratic compression time has been shown 
to result in reduced coughing strength for patients compared to healthy individuals (Lavorini 
et al., 2007).  
Neurological control for RC is very different than that for VC, implying that 
neurological impairment typically affects VC and RC in different ways. For example, a study 
that investigated VC and RC in patients following stroke found that they were independent of 
each other and that VC was impaired in 79% of right-handed patients who had suffered acute 
left-sided middle cerebral artery (MCA) infarcts but CR remained unimpaired and no patients 
developed aspiration pneumonia (Stephens et al., 2003). A similar study investigating VC 
and RC in stroke patients found that 10% of patients had a weak or absent CR, whereas 20% 
of patients had an abnormal VC (Addington, Stephens, & Gilliland, 1999). Addington et al. 
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(2005) also suggest that cerebral infarcts can result in transient, or permanent, ‘brainstem 
shock’ which can result in impaired cough reflex.  
 Ward et al. (2010) investigated the difference between RC and VC in patients 
following ischaemic hemispheric stroke and in healthy controls. They found that both VC and 
RC strength, as measured by peak cough flow rate and cough volume acceleration, were more 
impaired in patients than in healthy controls. However, when they directly stimulated the 
abdominal respiratory muscles by applying magnetic stimulation to the 10th thoracic nerve, 
they found that there was no impairment of coughing strength in patients. This implies that 
stroke can result in impairment of the cortical and involuntary control of coughing strength, 
but it does not cause impairment at the level of the abdominal expiratory muscles themselves 
(Ward et al., 2010). Unfortunately, they did not perform statistical analysis to compare their 
measures of VC and RC strength. As such, conclusions cannot be made about differences in 
strength following stroke or in healthy individuals.  
Research investigating VC and RC in patients with early stages of Parkinson’s disease 
has revealed that patients have a lower strength of VC and RC than healthy controls, as 
measured by EMG of abdominal muscles; however, they found that there was no difference 
in cough sensitivity (Fontana, Pantaleo, Lavorini, Benvenuti, & Gangemi, 1998). They 
hypothesized that this impairment of the motor control of coughing is a result of impairment 
of neurological control of respiratory muscles.   
2.4 Cough Reflex Testing 
Many tussigenic agents have been utilized to stimulate cough reflex, including tartaric 
acid, capsaicin, ultrasonically-nebulized distilled water, and citric acid. Citric acid is known 
to be a powerful tussigenic agent that stimulates both chemosensors and mechanosensors by 
acting on both C-fibres and RARs (Mazzone, 2005; Pecova et al., 2007). 
The citric acid inhalation cough challenge was first described in the mid-1950s and 
has been shown to be reproducible over time with healthy individuals (Morice et al., 2007). 
In recent years, there has been extensive research investigating the association between 
response to citric acid and the risk of silent aspiration. Cough reflex testing (CRT) has been 
shown to have reasonably high sensitivity and specificity in detecting silent aspiration (Miles, 
Moore, et al., 2013). Furthermore, it is now being used widely in clinical practice in New 
Zealand and has been found, when used with a management protocol, to substantially reduce 
the rate of aspiration pneumonia (Davies, Fink, & Huckabee, 2015).  
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Most of the research investigating CRT has examined natural cough reflex – in this 
test individuals are given instructions to ‘cough if they feel the need to’. However, Hutchings, 
Morris, Eccles, & Jawad (1993) have demonstrated that reflexive coughing to capsaicin can 
be voluntarily suppressed. This indicates that either cortical inhibition of RC is possible, or 
alternatively, that a true RC has not been initiated at all. The potential exists for patients 
undergoing natural CRT to cough voluntarily – rather than reflexively – during the 
assessment, because they are aware they are undergoing a cough test (Monroe, Manco, 
Bennett, & Huckabee, 2014). In order to offset this ‘placebo effect’, CRT can incorporate the 
assessment of suppressed coughing, where individuals are instructed ‘if you feel the need to 
cough, try to suppress it’. The rationale for using suppressed coughing as well as, or in lieu 
of, natural coughing is that there is increased likelihood that any coughs produced are truly 
reflexive as the person is no longer able to cortically suppress the response (Monroe et al., 
2014). The potential drawback of suppressed coughing is that patients with cognitive or 
communication impairments may not be able to follow instructions to suppress their cough. 
Research investigating natural and suppressed cough threshold in healthy people revealed 
that 22% of participants were able to suppress their cough at all concentrations of citric acid 
up to 2.6 Mol/L, whereas only 5% of participants did not produce a natural cough at the same 
concentrations. Furthermore, 90% of participants produced a natural cough response by 0.8 
Mol/L and 87% of participants produced a suppressed cough response by 0.8 Mol/L citric 
acid. However, these figures excluded any participants who did not respond to citric acid at 
any dose, therefore if these numbers were not excluded the percentages would have been 
85% and 65% respectively (Monroe et al., 2014). This indicates that some patients may have 
a pre-morbid disposition to lower cough sensitivity, and that the rate of this is considerably 
higher when assessing suppressed coughing.   
Clinically, the application of the cough reflex test (CRT) varies slightly in different 
localities. In a recent study conducted by Miles, Zeng, McLauchlan, & Huckabee (2013), the 
following protocol was used. Patients received 0.9% saline solution to acclimatize them to 
the test. They were subsequently presented with nebulized 0.8 Mol/L citric acid via a face-
mask for up to 15 s. Patients underwent this test a further two times, with a gap of at least 30 
s between trials to prevent tachyphylaxis. Perceptual judgement was made regarding whether 
the person produced a C2 response, two successive coughs not interrupted by inspiration, and 
whether their coughs are weak (too weak to clear material from the airway) or strong (strong 
enough to clear material from the airway). If they produced a strong C2 on at least two of the 
trials, they were deemed to have passed the first stage of the CRT. Patients who passed this 
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first stage then underwent a further ‘suppressed CRT’, where individuals were asked to ‘try 
not to cough’ during three trials of 0.8 Mol/L citric acid. Again, perceptual judgement of 
strength of coughing and C2 response were recorded. Those individuals who failed 
underwent a further suppressed CRT at 1.2 Mol/L. 
Addington, Stephens, Widdicombe, & Rekab (2005) highlighted that strength of 
coughing is an important factor in identifying risk of aspiration pneumonia, as they found that 
10% of stroke patients that were rated as having a weak cough went on to develop aspiration 
pneumonia compared with 15% of patients that were rated as having an ‘absent’ cough 
reflex. However, they did not provide clear definition as to what they meant by weak or how 
this rating was given.  Inter- and intra-rater reliability of perceptual judgement of strength of 
coughing are low (Miles & Huckabee, 2012). In addition, both experienced and 
inexperienced speech and language pathologists reported that this subjective perceptual rating 
is difficult. 
2.5 Objective Cough Strength Testing 
The effectiveness of coughing in clearing material from the airway is likely to be 
based on a number of factors, including the efficiency and strength of respiratory muscles, the 
efficacy of the laryngeal muscles, competent vocal cord functioning, rate of inspiratory flow, 
lung volume, and compression phase (Fontana & Lavorini, 2006; Magni et al., 2011; Smith & 
Wiles, 1998). It is vital that outcome measures that are chosen to assess strength of coughing 
incorporate as many of these aspects as possible. 
2.5.1 Cough Peak Flow 
One of the most widely used clinical measures of coughing strength has been the 
measurement of voluntary cough peak flow using spirometers or peak-flow meters. Cough 
peak flow is a reliable measure of the expiratory muscle strength needed for voluntary 
coughing (Tzani et al., 2014) and a good predictor of a person’s ability to protect their airway 
(Bianchi et al., 2012). For example, Smina et al. (2003) investigated cough peak flow in 
intubated intensive care patients by placing a peak flow meter in line with the endotracheal 
tube and asking the patient to cough. They were able to establish an optimum cough peak 
flow threshold of ≥60 L/min. They determined that patients with cough peak flows below 
this threshold were significantly more likely to fail extubation and 19.1 times more likely to 
die during their hospital stay.   
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The gold standard for measurement of cough peak flow is the pneumotachograph 
(Silverman et al., 2014). Pneumotachography works by measuring the expiratory flow rate 
during a voluntary cough. Portable peak-flow meters have been found to be highly correlated 
with pneumotachography in healthy individuals and in patients with neuromuscular disease 
(Sancho, Servera, Díaz, & Marín, 2004). However, other research has indicated decreased 
accuracy of portable peak flow meters with peak flows of less than 400 L/min (Jackson, 
1995) and that flow measures are often underestimated with this method (Rebuck, Hanania, 
D’Urzo, & Chapman, 1996). 
The research conducted by Smina et al. (2003) also found that 4 of the 9 patients who 
died during their hospital stay had cough peak flows below the threshold of 60 L/min and 
were found to be aspirating. This reveals the strong potential for cough peak-flow 
measurement to identify patients at risk of pulmonary complications as a result of aspiration. 
The disadvantage of using peak flow meters to measure cough strength is that the device 
requires a patient to be able to follow instructions; as a result, this method is often not 
appropriate for use with patients with cognitive or communication impairment (Smina et al., 
2003; Smith Hammond et al., 2001). In addition, patients who have facial or labial weakness, 
as is often seen following stroke, often struggle to produce airtight lip seal around the peak 
flow meter mouthpiece (Chatwin et al., 2003). Moreover, peak flow meters used in this way 
are measuring the strength of a voluntary cough. In the dysphagic population, strength of 
reflexive coughing is of greater interest, as this influences the ability to protect their airway 
following an aspiration event. 
Boitano (2006) hypothesized that the coordinated action of the glottis and the 
respiratory muscles in the compressive and expulsive phases of coughing are particularly 
crucial in the production of an effective cough. However, other research has suggested that 
the glottis has little effect on coughing pressure and strength. As evidence, patients who have 
undergone laryngectomy and do not have a glottis have been found to have similar cough 
peak flow as patients with a glottis (Fontana et al., 1999). However, the methodology for this 
research involved placing an airtight mask over the laryngectomy stoma. It could be 
hypothesized that this airtight mask would, in effect, serve as a substitute for the glottis and 
facilitate a build-up of pressure that would not be present with an open laryngectomy stoma. 
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2.5.2 Thermal Measures of Cough 
 Drugman et al. (2013) looked at multiple aspects of coughing using various devices. 
They found that the thermistor was slow-varying but gave the most information about 
respiratory volume. However, the thermistor is not a reliable detector of coughing as it is 
easily affected by forced expiration, throat clearing, and background noise. In addition, 
thermistors provide an indirect measure of airflow during coughing and are highly influenced 
by temperature and humidity level. Therefore, it is unlikely to provide a reliable measure of 
strength of reflexive coughing with nebulized citric acid (Farré, Montserrat, Rotger, Ballester, 
& Navajas, 1998). 
2.5.3 Acoustic Measures of Cough  
Cough effort or energy can be measured by acoustically recording coughs and 
determining the integral of the acoustic power spectrum (Morice et al., 2007). Cough 
intensity can be measured by dividing the total cough effort by the cough count and is 
thought to be a good indicator of the effectiveness of coughing (Pavesi, Subburaj, & Porter-
Shaw, 2001).  
 Drugman et al. (2013) investigated the accuracy of various cough detection devices. 
The focus of their study was the specificity and sensitivity of the different devices in 
measuring the frequency of coughing in varying environmental conditions. However, they 
also collected data on a wide range of features, including the energy and loudness of the 
recorded signals and the amplitude of the waveform. They found that when limiting each 
device to their two best features, the best sensors were the audio microphone followed by the 
accelerometer positioned on the throat.  
 Pavesi et al. (2001) assessed audio-vibration signals of coughing using a calibrated 
accelerometer attached to the suprasternal notch of the patient. Attaching the accelerometer to 
this location was found to improve accuracy of measurements, as interference from vibrations 
caused by speech and swallowing was excluded (Paul et al., 2006). They found this 
methodology to be reliable and effective in obtaining objective measures of coughing, 
including information about frequency of coughing, cough sequences, cough effort, and 
cough intensity. In a previous study, the same team used a miniature microphone attached to 
the lateral aspect of the left nostril to record cough sound. In this study they found that the 
coughing intensity reduced with increasing distance between the microphone and the source. 
They reported that coughing intensity was more affected by horizontal distance from the 
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source than vertical distance. They highlighted the importance of careful positioning of the 
microphone to ensure reproducibility and consistency within and between subjects. They also 
reported that coughing intensity was affected by temperature and humidity, which suggests 
that audio-microphones attached to the nose may not be the best method for examining cough 
strength when using nebulized citric acid (Subburaj, Parvez, & Rajagopalan, 1996). 
 Smith Hammond et al. (2009) examined voluntary coughing in stroke patients using 
an air-tight face mask attached to a pneumotachograph to measure airflow and microphone 
attached to the face mask to measure sound pressure levels. They found that sound pressure 
level was associated with aspiration risk, as measured by Videofluoroscopic Swallowing 
Study (VFSS) or Fibreoptic Endoscopic Evaluation of Swallowing (FEES). Patients who 
developed aspiration pneumonia had lower average sound pressure levels. However, they 
also hypothesized that acoustic measures of coughing strength were influenced by the 
quantity of chest secretions which can result in over-estimation of coughing strength in more 
productive patients  (Smith Hammond et al., 2001).  
2.5.4 Electromyography of Cough 
  Pitts et al. (2014) investigated abdominal, thoracic, laryngeal, and pharyngeal muscle 
activity using fine-wire electromyography (EMG) on anaesthetized cats. They found that the 
greater the aspiration risk, the larger the EMG amplitudes in the inspiratory, expiratory, and 
thyrohyoid muscles. This suggests a potential for a dose effect of citric acid on strength of 
coughing. 
Fontana, Pantaleo, Lavorini, Boddi, & Panuccio (1997) also used EMG of abdominal 
muscles activity to measure coughing intensity in response to inhaled ultrasonically nebulized 
distilled water with outputs varying from 0.08 to 4.45 mL/min. They found a positive linear 
relationship between dose of stimulus and strength of coughing. However, they highlighted 
the fact that strength of coughing was dependent on more than just expiratory muscle 
function and effort (Fontana et al., 1997). Cox et al. (1984) also used EMG of abdominal 
muscles to investigate coughing intensity in response to citric acid and similarly found a 
dose-dependent increase in coughing intensity.  
Vovk et al. (2007) used EMG to investigate LER and CR in healthy participants using 
capsaicin stimulus. They also found an increase in strength of coughing with greater doses of 
capsaicin. They found that EMG activity of abdominal and thoracic muscles was proportional 
to respiratory muscle contraction and correlates strongly with airflow measures. However, 
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they also reported that methods for analysing EMG measures are high variable which can 
make between-study evaluations problematic.  
There are other reported limitations of using EMG for assessment of coughing 
strength. Consistency in the placement of electrodes can be challenging, which results in a 
high degree of variability in intra- and inter-subject measurements (Cox et al., 1984). There 
are signal variations with greater levels of abdominal fat content, skin resistance, muscle size, 
and distance between electrodes. These factors result in a high level of variability in coughing 
strength measures between and within individuals (Pitts & Bolser, 2011). These reports imply 
that EMG may be a less reliable method of coughing intensity measurement. In addition, 
some of these studies were utilising EMG to measure coughing intensity in respiratory 
impairment or chronic cough (Cox et al., 1984; Fontana et al., 1997), where any deficits in 
strength are likely to be at the respiratory muscle level. In contrast, patients who have 
impaired coughing secondary to neurological deficit may expect to have deficits at the 
laryngeal level or with coordination of respiratory muscles and glottal functioning, these 
deficits can result in a reduction in coughing strength that may not be captured by EMG of 
abdominal or thoracic muscles (Fontana & Widdicombe, 2007). Therefore, EMG may not be 
the best measure of coughing strength in patients with neurogenic dysphagia.  
2.5.5 Cough Pressures 
Coughing strength can also be assessed by measuring intra-abdominal pressures using 
urethral and rectal catheters. Addington, Stephens, Phelipa, Widdicombe, & Ockey (2008) 
used this method to assess VC and RC in response to inhaled tartaric acid. They found that 
area-under-the-curve (AUC) pressure was greater for RC than for VC; however, they were 
comparing the entire cough sequence which comprised small numbers of VC (mean of 1.8 
coughs) with large numbers of CRs (mean 6.0 coughs). If the AUC of one VC was compared 
with one RC then it is highly likely that the results would be reversed, with VC strength being 
greater that RC. Interestingly, they observed significantly lower duration of intra-abdominal 
pressure with VC compared to RC, where glottic abduction occurred during cough producing 
a coinciding reduction in pressure. They suggests that sustained intra-abdominal pressure 
during RC is an important aspect of airway protection, as the glottis remains closed except 
during the very rapid vocal cord abduction during the expulsive phase of cough. They also 
concluded that recording the AUC of a cough measure is important to provide information 
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about an entire cough, as the pressure over the duration of a cough can vary between VC and 
CR (Addington et al., 2008).  
It has been demonstrated that cough gastric pressures are normal in patients following 
stroke, whereas respiratory measures of coughing strength, including flow rate and expired 
volume, are reduced (Addington et al., 1999). It was hypothesized that gastric measures of 
coughing are not indicative of actual coughing strength as they do not encompass 
measurement of impairment at the upper airway. 
It is also possible to assess coughing strength by measuring intra-oesophageal 
pressures using pressure transducers (Young, Abdul-Sattar, & Caric, 1987) or a balloon 
catheter (Pitts et al., 2014). However, these methods, along with EMG and intra-abdominal 
pressure measurements are considered to be clinically impractical.  
Nasal pressure cannulas are used to measure air pressure fluctuations that take place 
during inspiration and expiration. They have been widely used in sleep studies and have been 
shown to be reliable and sensitive for detection of apnoea and hypopnea (Thurnheer, Xie, & 
Bloch, 2001). Nasal pressure measures of respiration have been shown to be comparable with 
facemask pneumotachography, which is the gold standard quantitative measurement for 
respiration in sleep (Thurnheer et al., 2001). They have also been shown to be more sensitive 
than thermocouples or thermistors to subtle changes in airflow and airway resistance, 
indicating the potential of pressure measurements for use in cough strength testing1. 
Szeinberg et al. (1988) investigated cough capacity in patients with muscular dystrophy and 
reported that this maximal expiratory pressure provides more accurate representation of 
coughing strength than forced vital capacity or peak expiratory flow rates. Moreover, Fontana 
et al. (1999) found no significant difference in cough expiratory flow in individuals with 
laryngectomy and healthy individuals and hypothesized that the closure of the glottis during 
the compressive phase of a cough is not important to cough peak flow. This implies that 
measures of cough pressure, which is likely to incorporate information about the compressive 
phase of a cough, may provide more accurate measures of the efficacy of coughing.  
                                                 
1 Rapoport, D., Norman, R., & Nielson, M. (2001). Nasal Pressure Airflow Measurement An Introduction. Pro-
Tech Services, Inc. 
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2.6 Gaps in the Research 
Cough reflex testing provides information about the sensitivity of the cough reflex 
and enables the identification of patients who are at risk of silent aspiration with high 
sensitivity and specificity (Miles, Moore, et al., 2013). However, subjective judgements of 
strength of reflexive cough are unreliable which has highlighted a need for a reliable 
objective assessment (Miles & Huckabee, 2012; Spinou & Birring, 2014). This is vital so that 
CRT can provide more thorough information about the patient’s reflexive coughing and 
enable more precise identification of patients at risk of developing aspiration pneumonia. 
Despite many studies into strength of voluntary coughing using a variety of measures, 
there has been limited research investigating the strength of reflexive cough. Several studies 
have examined dose effects on strength of reflexive coughing using sEMG and found a 
positive relationship (Cox et al., 1984; Fontana et al., 1997). However, as reported 
previously, this method is clinically impractical and has the potential to provide inaccurate 
results for the neurogenic dysphagic population.  
Investigations into cough peak flow have predominantly targeted voluntary coughing 
using a closed system, with an airtight mask or a mouthpiece (Smith Hammond et al., 2001, 
2009; Ward et al., 2010). Using the assessment of VC to make judgements about a person’s 
ability to reflexively protect their airway is problematic. Assessment of VC only provides 
information about damage to the cortical control of coughing and respiratory muscle 
weakness; it gives no information about the brainstem-mediated control of RC, which is of 
particular interest with regards to aspiration risk (Widdicombe et al., 2011). The other 
potential problem with using measures of VC to judge aspiration risk, is that assessment 
requires the person to understand and follow instructions, whereas as RC can be assessed 
without needing a specific level of cognition or communication skills (Widdicombe et al., 
2011). A few studies have investigated RC strength utilizing measures of airflow, via a 
mouthpiece attached to a pneumotachograph, and reported greater strength with increasing 
dose of stimulus (Fontana et al., 1997; Vovk et al., 2007).  The general consensus is that 
measures of flow are easy, non-invasive, inexpensive and the most clinically practical 
methods for measurement of coughing strength (Spinou & Birring, 2014).  
In summary, there has been minimal research conducted into RC strength testing and 
there is no currently clinically practical approach to objectively measure RC strength. 
Furthermore, all RC strength studies have examined natural cough reflex rather than 
suppressed cough reflex, which is believed to be a more reliable way to elicit a true RC. 
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Additionally, there have been no reported investigations of coughing strength using direct 
measures of pressure; however, research supports this as a potentially reliable and accurate 
outcome measure, and it is vital to explore this.  
2.7 Problem Statement 
Easy to access and inexpensive methods are available to assess the sensitivity of an 
individual’s coughing using CRT and the strength of a person’s VC using portable peak flow 
meters. However, evidence suggests that VC and RC are quite different and affected 
differently by neurological impairment. Thus, assessment of VC strength is an unreliable 
indicator of how effective RC is in protecting the airway and clearing aspirated material from 
the lungs. At this time, there is no established method of objectively measuring the RC 
strength of individuals produced during sensory testing. Developing a low-cost, simple 
method to assess coughing sensitivity and strength simultaneously is likely to provide more 
comprehensive information about the efficacy of a person’s coughing (Widdicombe et al, 
2011). This would enable more accurate estimation of an individual’s risk of aspiration 
pneumonia so that this risk can be managed effectively to reduce pneumonia rates, mortality 
rates, length of hospital stay, and improve quality of life. 
2.8 Objective and Hypotheses 
The objective of this study was to investigate the use of a pressure transducer, a 
spirometer, and a microphone to measure the relative strength of the suppressed RC elicited 
by varying doses of citric acid challenge and compare this to VC strength in healthy 
individuals.  
The following hypotheses were tested: 
1. The pressure sensor will provide a sensitive measure of strength of coughing 
in healthy individuals. 
2. The flow rate sensor will provide a sensitive measure of strength of coughing 
in healthy individuals. 
3. The microphone will provide a sensitive measure of strength of coughing in 
healthy individuals.   
4. The pressure sensor will provide the most accurate measure of strength of 
coughing in healthy individuals. 
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5. A higher concentration of inhaled citric acid will produce increased RC 
strength. 
6. A strong VC will be stronger than a RC cough stimulated by citric acid. 
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 Methodology 
3.1 Study Design 
A within-subject design was utilized to investigate strength of reflexive and voluntary 
coughs. Participants underwent a citric acid cough reflex challenge provided via a face mask 
connected to a nebulizer. Simultaneous measurements of cough pressure, cough flow and 
cough acoustics were taken in response to citric acid stimulation. VC was also measured 
using the same equipment in the same conditions.  
3.2 Ethical considerations 
The University of Canterbury Human Ethics Committee granted ethical approval prior 
to the commencement of data collection. Subjects gave written consent for the study after 
having been provided with verbal and written explanations about the procedures (see 
Appendix 1 and 2) and opportunities to ask questions. 
3.3 Participants 
Published research investigating coughing strength in healthy participants did not 
provide appropriate data to support sample size calculation. However, a sample size of 30 or 
below has previously been adequate to identify significant differences in coughing strength 
under different conditions; therefore, an initial sample size of 30 was chosen (Chatwin et al., 
2003; Cox et al., 1984; Fontana et al., 1997). Exclusion criteria included: individuals below 
the age of 50, gastro-oesophageal reflux, respiratory conditions, neurological conditions, 
dysphagia, smokers and people taking steroids, opiates or who had taken codeine-based 
analgesia in the 24 hours prior to assessment. Preliminary statistics and power analysis were 
to be completed following acquisition of 30 sets of data. However, due to time constraints, 
this proposed interim analysis represent the conclusion of this research project.  
Participants were recruited via community groups (e.g., Probus groups, Rotary groups 
and church groups) using the advertisement shown in Appendix 3. Fifty-four healthy 
individuals, 33 females and 20 males, were initially recruited for the study. However, of these 
only 29 (20 females and 9 males) were considered suitable for inclusion for data analysis (see 
Results for information on data exclusion). The participants included had a mean age of 61, 
with a range of 50 to 84. 
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3.4 Resources 
Citric acid solutions at concentrations of 0.4, 0.8, 1.2 and 1.8 Mol/L, as well as 0.9% 
saline, were sourced from the University of Canterbury Chemistry Department and 
appropriately stored. A PulmoMate® Compressor Nebulizer (model 4650I) (DeVilbiss 
Healthcare LLC, Pennsylvania, US) was used to deliver the citric acid stimulus to 
participants. A pre-determined free-flow output of 8 L/min and a restricted flow output of 6.6 
L/min was utilized to ensure consistency in the dispersal of the citric acid within and between 
subjects (Morice et al., 2007). This same flow output was also used, to apply nebulized room 
air only during VCs to ensure identical airflow and pressure conditions. 
The AD Instruments physiological pressure transducer (Model MLT844) was 
connected to a bridge amp (Model ML110) and a respiratory flow head 1000 L (MLT1000L) 
was connected to a spirometer pod (Model ML311) (Figure 1). These were utilized to collect 
information on cough pressure and cough flow rate, respectively. A Littmann stethoscope 
was attached to an Optimus omnidirectional impedance microphone (1KΩ Model 33-3003) to 
obtain acoustic measures of coughing (Figure 2). All instruments were connected to an AD 
PowerLab 26T-3819 (model ML856) (Figure 1) and LabChart Version 7.3.7 was utilized to 
collect and analyse data. A disposable Hudson RCI MICRO MIST® adult, elongated aerosol 
nebulizer mask and 7-foot Start Lumen® Tubing were used for each participant. This face 
mask had detachable tubing attached to each port: one connected to the pressure transducer, 
and one connected to the spirometer flow head (Figure 3). Medizyme proteolytic enzyme 
cleaner was used to clean all equipment, except the disposable face mask, after each 
assessment. The full set up of equipment can be seen in Figure 4. 
The following equipment preparation was conducted before each procedure: 
1. Flow measures: 
a. The spirometer was zeroed and calibrated using the following parameters –  
0.0 mV = 0.0 L/s and 1.0 V = 40.1L/s 
b. Recording range was set at 500 mV 
c. Low pass filter was set at 30 Hz 
d. Anti-alias filter was turned on 
2. Pressure measures: 
a. The pressure transducer was calibrated manually using a sphygmomanometer. 
b. Recording range was set at 2 mV 
c. Low pass filter was set at 2 kHz 
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d. High Pass DC filter was turned on  
e. Anti-alias filter was turned on 
3. Acoustic measures: 
a. No calibration was necessary 
b. Recording range was set at 2 V 
c. Low pass filter was turned off 
d. Anti-alias filter was turned on 
4. For all measures the sampling rate was set at 10 kHz. 
5. The nebulizer was set as far away from the recording equipment and the participant as 
possible to prevent artefacts in sound and pressure recordings. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Set-up of spirometer flow head, spirometer pod, PowerLab and bridge amplifier. 
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MEASURING VOLUNTARY AND REFLEXIVE COUGH STRENGTH IN HEALTHY INDIVIDUALS  26 
 
 
 
 
Figure 2. Littmann stethoscope attached to microphone on a neck strap. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Face mask with tubing attached. 
 
 
 
 
 
 
 
 
 
Figure 4. Full set-up of equipment. 
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3.5 Procedure 
A counterbalanced design determined if the participant commenced data collection 
with voluntary or reflexive coughs. In addition, execution of the type of VC: a strong single 
cough, two strong coughs, a single weak cough, or two weak coughs, were varied randomly 
for each participant (see Appendix 4 and 5 for details).  
For RC, participants were initially given 0.9% saline solution via a facemask as per 
the European Respiratory Society (ERS) guidelines on the assessment of cough (Morice et 
al., 2007). This served to reduce or prevent the ‘startle phenomenon’, of excessive coughing 
on the first trial of tussive agent inhalation, which has been reported with capsaicin 
(Dicpinigaitis, 2003, p. 64). Placebo was also applied after each trial of citric acid to improve 
blindness of the study by preventing participants from anticipating dosages and consequently 
giving conditioned responses (Morice et al., 2007).  
A counterbalanced approach to dose order of citric acid was not possible due to the 
tendency for higher concentrations of citric acid to influence subsequently-applied lower 
concentrations as there is a greater risk of tachyphylaxis with higher doses of citric acid. 
Therefore, the lower doses of citric acid were administered first, followed by the higher 
doses, adhering to the ERS guidelines (Morice et al., 2007). Citric acid was administered for 
no more than 15 s, adhering to current clinical practice, as continual inhalation of citric acid 
over a period of a minute or more has been shown to result in tachyphylaxis (Morice et al., 
2007). Each dose of citric acid was administered once only. When a C2 response was 
observed on three consecutive and increasing doses of citric acid, no further doses of citric 
acid were presented. 
The following procedures took place with each individual. The face mask was 
securely placed with the straps tightened; the nose piece was adjusted to reduce movement of 
the mask during the assessment and minimize air escape. The stethoscope attached to the 
microphone was placed centrally on the neck over the participant’s larynx using a neck strap. 
A central position was chosen in order to reduce artefact of pulse detection, which frequently 
occurred when the stethoscope was placed on the lateral aspect of the larynx. For VC, 
participants were asked to do each of the following whilst the nebulizer was running with an 
empty chamber: 
1. “take a breath in and produce 1 strong cough” 
2. “take a breath in and produce 2 strong coughs on one breath” 
3. “take a breath in and produce 1 weak cough” 
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4. “take a breath in and produce 2 weak coughs on one breath” 
The different types of cough were modelled for participants. A 60 s rest period was given 
between each type of cough. If participants felt that they had not carried out the task 
adequately or if they were observed to perform the coughs incorrectly, for example, if they 
inhaled between coughs, they were requested to repeat the attempt. 
For RC, participants were given the instruction “Breathe in and out through your 
mouth. If you feel the need to cough, try to suppress it”. The placebo was applied through the 
nebulizer for 15 s. This was also repeated after citric acid doses of 0.4, 0.8, and 1.2 Mol/L. 
All citric acid trials were administered through the nebulizer for up to 15 s. If a C2 response 
was not observed at any of the previous doses then citric acid of 1.8 Mol/L was applied 
through the nebulizer for up to 15 s. With all citric acid trials, as soon as a C2 response was 
observed the nebulizer was turned off. Again, a rest period of at least 60 s was given after all 
trials of citric acid or placebo.  
The AD PowerLab system was used to record the data obtained from the pressure 
transducer, the spirometer and the microphone. A video-recording of the procedure was also 
taken, with the participants’ consent, to allow analysis of the coughs post-procedure. 
3.6 Data Extraction 
3.6.1 Procedure 
The pressure and acoustic signals were digitally filtered post-recording to reduce 
baseline drift. Pressure was filtered using a 2 Hz high-pass digital filter and acoustic using a 
20 Hz high-pass digital filter.   
C2 responses were identified using the airflow waveform to ensure that there was no 
inspiration between the first and second cough. C2 responses were recorded for each of three 
consecutive doses and labelled as ‘dose 1’, ‘dose 2’, and ‘dose 3’. This means that for some 
participants threshold dose, or dose 1, was 0.4 Mol/L, and for others it was 0.8 Mol/L, 
depending on their individual responses. The following events of interest were then identified 
and extracted for each of the VCs and for the first and second cough of the C2 response for 
each citric acid dose: 
 The cough peak flow, the cough peak pressure and the peak amplitude of the cough 
acoustics for each VC and for the C2 response for each citric acid challenge. 
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 The area under the curve (AUC) of the cough flow rate, the rectified cough pressure, 
and the rectified acoustic waveform. 
In order to extract these data the following procedures were implemented: 
 ‘s’ markers were manually placed up to 1 s before the beginning of activity in the 
rectified acoustic waveform for each cough 
 ‘e’ markers were manually placed up to 1 s after the end of activity in the rectified 
acoustic waveform for each cough. 
 ‘b_1’ marker was placed during the first placebo trial and ‘b_2’ marker was placed 3 
s later, in order to mark a baseline for the rectified acoustic waveform where there 
was nebulizer running but there was no coughing or vocalizations.  
 A macro was written for PowerLab which calculated the mean and standard 
deviation of this baseline. The code then calculated a threshold by adding 7 times the 
standard deviation to the baseline. This threshold was then utilized to place ‘start’ 
and ‘end’ markers. The macro found the ‘s’ marker, searched up to 1 second after 
this marker and placed a ‘start’ marker as soon as the rectified acoustic waveform 
rose above the threshold. Likewise, it found the ‘e’ marker and searched up to 1 s 
backwards and placed an ‘end’ marker as soon as the rectified acoustic waveform 
rose above the threshold (see Figure 5 for an example of marker placement). 
 For some coughs, no ‘start’ or ‘end’ were detected, as the waveform did not rise 
above the threshold. In these cases the ‘start’ and ‘end’ markers were manually 
placed where the airflow or pressure first rose above and returned to baseline (see 
Figure 6 for an example). 
 For other coughs, the rectified acoustic waveform did not closely match the airflow 
and pressure measures and resulted in substantial clipping of the airflow and/or 
pressure waveforms. In cases where this clipping included loss of the peak of either 
flow or pressure, the ‘start’ and/or ‘end’ markers were manually modified. In these 
instances, ‘start’ and ‘end’ markers were manually placed where the airflow or 
pressure first rose above and returned to baseline (see Figure 7 for an example).  
 Once ‘start’ and ‘end’ markers were placed, a further macro was utilized to place the 
peak and AUC information for each outcome measure into the software datapad. 
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Figure 5. Automatic marker placement for two strong voluntary coughs from participant 14B. 
‘Start’ and ‘End’ markers have been automatically placed within the manually placed ‘s’ and 
‘e’ markers. The 1st waveform is pressure (red), 2nd waveform is airflow (blue), 3rd waveform 
is raw acoustic (dark green), and 4th waveform is rectified acoustic (pale green). 
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                           (a)                                                                        
                 
 
 
 
 
 
 
 
 
 
 
                                       (b)      
 
 
 
 
 
 
 
 
 
 
Figure 6. Manual placement of markers for citric acid 1.8M/L for participant 50B: (a) ‘Start’ 
and ‘End’ markers were placed for cough 2 but no ‘Start’ or ‘End’ markers were placed for 
cough 1 as the rectified acoustic waveform did not go above threshold. (b) ‘Start’ and ‘End’ 
markers were manually placed for cough 1 where the airflow and pressure started to rise 
above baseline. The 1st waveform is pressure (red), 2nd waveform is airflow (blue), 3rd 
waveform is raw acoustic (dark green), and 4th waveform is rectified acoustic (pale green). 
 
 
 
 
End s s e Start e 
End 
s s e eStart Start End 
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                                a).                                                                                           
 
 
 
 
 
 
 
 
                                  
 
b). 
 
 
 
 
 
 
 
 
 
 
Figure 7. Manual placement of markers for two voluntary weak coughs from participant 
16D: (a).‘Start’ and ‘End’ markers were placed for both cough 1 and 2 but the start marker 
clips the peak of the pressure and flow. (b) ‘Start’ marker was manually placed for cough 1 
where the airflow and pressure started to rise above baseline. The 1st waveform is pressure 
(red), 2nd waveform is airflow (blue), 3rd waveform is raw acoustic (dark green), and 4th 
waveform is rectified acoustic (pale green). 
 
3.6.2 Rationale 
Provisional analysis of the data revealed that the pressure waveform closely mirrored 
the acoustic waveform, both characterized by high frequency waveform that passes 
End s s e eStart Start End 
End s s e eStart Start End 
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frequently into the negative. It was hypothesized that this was likely due to small changes in 
pressure at the level of the vocal cords during a cough as a result of the Bernouilli Effect 
creating negative pressure in the glottis (Tao, Jiang, & Zhang, 2006; Van Den Berg, Zantema, 
& Doornenbal, 1957). Therefore, peak and AUC measurements were derived from the 
rectified pressure waveform. Utilizing the rectified waveform enabled all the energy of a 
cough captured by the pressure transducer to be analysed. Likewise, the rectified acoustic 
waveform was used to obtain peak and AUC measurements.  
There were many factors to take into consideration when choosing which outcome 
measure to select for the macro to use to place automatic ‘start’ and ‘end’ markers. The 
airflow waveform tended to begin slightly before pressure and acoustic measures and finish a 
considerable time after they finished. Therefore, airflow should have been an ideal candidate 
for selection. However, the highly fluctuating baseline, due to inspiration and expiration, 
rendered it unsuitable for automatic placement of cough markers. The pressure waveform and 
the rectified pressure waveform, once a high-pass digital filter was applied, had stable 
baselines and potential for selection. However, on trialling the pressure waveform and the 
rectified pressure waveform for automatic cough marker placement, it became apparent that 
the pressure waveforms tend to be considerably shorter than the acoustic and airflow 
measures and there was substantial clipping of other waveforms. The rectified acoustic 
waveform was thus chosen for automatic placement of ‘start’ and ‘end’ markers. Using this 
waveform provided the least amount of clipping of other waveforms and was felt to be the 
optimum choice.  
The decision to use seven times the standard deviation of the baseline in order to 
calculate the threshold was made after running trials with the macro using different threshold 
calculations. Using 7xSD gave the most consistent placement of ‘start’ and ‘end’ markers 
with the least amount of clipping of pressure and flow measures.  
Where the automatic markers clipped peaks of airflow or pressure, or were not placed 
at all, markers were manually placed. The ‘start’ markers were placed whenever pressure or 
flow first started to rise above the baseline. The rationale for this was that on some occasions 
the flow commenced before pressure, whereas at other times pressure commenced before 
flow. Without exception, cough flow duration was longer than cough pressure duration and, 
therefore, ‘end’ markers were always manually placed where airflow measure approaches the 
baseline.  
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3.7 Data Analysis 
The data were then further analysed using the IBM SPSS Statistics software (version 
22). Repeated-measures analysis of variance (ANOVA) was used to compare the peak values 
and the AUC for the different doses of citric acid and for the different types of VC for each of 
the three measures: pressure, flow, and acoustics. Analysis of sphericity was evaluated using 
Mauchly’s test of sphericity, when sphericity was violated either the Greenhouse-Geisser or 
Huynh-Feldt estimates of sphericity were used to correct the degrees of freedom.   
Paired t-tests were utilized to compare the third dose of citric acid to strong voluntary 
coughs. The root mean square error (RMSE) was used to estimate, on average, how far the 
modified data, taken by manually placing markers, deviated from the unmodified data from 
automatic placement of markers. A p-value of < 0.05 was considered as significant with a 
95% confidence interval. A bivariate correlation analysis was conducted to compare the 
Pearson’s correlation coefficient of the six different outcome measures.  
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 Results 
Twenty-nine sets of data were included in the study for analysis. Of the 24 sets of data 
excluded from analysis, 2 were due to equipment failure, 6 were due to human error, and 16 
were due to absent C2 response at three consecutive and incremental doses of citric acid. 
Thirty-two percent of the participants, 50% of whom were male, did not show the expected 
C2 response. 
4.1 Reflexive Cough 
4.1.1 Pressure 
The means and standard errors for peak pressure and AUC pressure are shown in 
Figures 8 and 9. For both measures there was a significant main effect of cough sequence (1st 
or 2nd cough in a sequence) (Peak: F(1) = 11.88, p < .01, 1-𝛽 = .91; AUC: F(1) = 30.76, p < 
.01, 1-𝛽 = 1.00). On average, the second cough was weaker than the first (Peak: mean 1st 
cough = 2.27 mmHg, mean 2nd cough = 1.84 mmHg, p < .01; AUC: mean 1st cough = 0.08 
mmHg.s, mean 2nd cough = 0.05 mmHg.s, p < .01). There was no significant effect of dose 
for either measure (Peak: F(2) = 0.44, p = .65, 1-𝛽 = .12; AUC: F(1.77) = 0.12, p = .86,  1-𝛽 
= .07). 
 
 Figure 8. Mean peak pressure for reflexive cough. 
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Figure 9. Mean AUC pressure for reflexive cough. 
 
4.1.2 Flow 
Figures 10 and 11 outline the means and standard errors for peak and AUC flow. 
There was a significant effect of cough sequence (1st or 2nd cough in a sequence) for both 
measures (Peak: F(1) = 33.25, p < .01, 1-𝛽 = 1.00; AUC: F(1) = 10.65, p < .01, 1-𝛽 = .88). 
On average, the first cough was stronger than the second (Peak: mean 1st cough = 0.95 L/s, 
mean 2nd cough = 0.67 L/s, p < .01; AUC: mean 1st cough = 0.15 L, mean 2nd cough = 0.10 L, 
p < .01 L). There was no significant effect of dose for either measure (Peak: F(2) = 0.05, p = 
.95,  1-𝛽 = .06; AUC: F(2) = 2.37, p = .10,  1-𝛽 = .46). 
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Figure 10. Mean peak flow for reflexive cough. 
 
 
 
 
Figure 11. Mean AUC flow for reflexive cough. 
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4.1.3 Acoustic 
Figures 12 and 13 demonstrate the means and standard errors for peak and AUC 
acoustic. There was a significant main effect of cough sequence (1st or 2nd cough in a 
sequence) for both measures (Peak: F(1) = 4.51, p = .04, 1-𝛽 = .54; AUC: F(1) = 10.94, p < 
.01, 1-𝛽 = .89). On average, the first cough was stronger than the second (Peak: mean 1st 
cough = 0.41 V, mean 2nd cough = 0.36 V, p = .04; AUC: mean 1st cough = 0.02 V.s, mean 
2nd cough = 0.01 V.s, p < .01). There was no significant effect of dose for either measure 
(Peak: F(1.73) = 0.56, p = .93, 1-𝛽 = .06; AUC: F(1.75) = 0.56, p = .93,  1-𝛽 = .06). 
 
 
Figure 12. Mean peak acoustic for reflexive cough. 
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Figure 13. Mean AUC acoustic for reflexive cough. 
 
4.2 Voluntary Coughs 
4.2.1 Pressure 
The peak and AUC pressure means and standard errors are displayed in Figures 14 
and 15. Both measures demonstrated a significant main effect of type of VC, strong or weak 
(Peak: F(1) = 57.73, p < .01, 1-𝛽 = 1.00; AUC: F(1) = 54.09, p < .01, 1-𝛽 = 1.00). This 
indicates that strong coughs are objectively stronger than weak coughs (Peak: mean weak 
cough = 1.85 mmHg, mean strong cough = 6.87 mmHg, p < .01; AUC: mean weak cough = 
0.11 mmHg.s, mean strong cough = 0.28 mmHg.s, p < .01). There was also a significant main 
effect of cough sequence (1st or 2nd cough in a sequence) for both measures (Peak: F(1) = 
16.48, p < .01, 1-𝛽 = .98; AUC: F(1) = 59.47, p < .01, 1-𝛽 = 1.00). This shows that the first 
cough is stronger than the second cough (Peak: mean 1st cough = 4.85 mmHg, mean 2nd 
cough = 3.87 mmHg, p < .01; AUC: mean 1st cough = 0.24 mmHg.s, mean 2nd cough = 0.14 
mmHg.s, p < .01). There was a significant interaction between type of cough and cough 
sequence for both measures (Peak: F(1) = 27.04, p < .01, 1-𝛽 = 1.00; AUC:  F(1) = 27.04, p < 
.01, 1-𝛽 = 1.00). This demonstrates that there is a greater difference between cough 1 and 
cough 2 for strong coughs than for weak coughs (Peak: mean difference strong = -1.75 
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mmHg; mean difference weak = –0.21 mmHg; AUC: mean difference strong = –0.15 
mmHg.s; mean difference weak = –0.03 mmHg.s). Peak pressure also exhibited a significant 
interaction between cough sequence and gender for peak pressure (F(1) = 11.30, p < .01, 1-𝛽 
= .90). This revealed that the decrease in strength from cough 1 to cough 2 was greater for 
males than for females (males mean difference = –1.52 mmHg; females mean difference = –
0.44 mmHg).  
 
 
Figure 14. Mean peak pressure for voluntary cough. 
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Figure 15.  Mean AUC pressure for voluntary cough. 
 
4.2.2 Flow 
Figures 16 and 17 reveal the means and standard errors for peak and AUC flow. There 
was a significant main effect of type of VC, strong or weak, for both measures (Peak: F(1) = 
20.54, p < .01, 1-𝛽 = .99; AUC: F(1) = 44.40, p < .01, 1-𝛽 = 1.00). This indicates that the 
strong coughs were quantitatively stronger than the weak coughs (Peak: mean weak cough = 
1.24 L/s, mean strong cough = 1.72 L/s p < .01; AUC: mean weak cough = 0.19 L, mean 
strong cough = 0.30 L p < .01). There was also a significant main effect of cough sequence 
(1st or 2nd cough in a sequence) for peak flow (F(1) = 66.77, p < .01, 1-𝛽 = 1.00) revealing 
that the first cough was stronger than the second cough (mean 1st cough = 1.65 L/s, mean 2nd 
cough = 1.31 L/s, p < .01). There was also a significant interaction of cough sequence and 
gender for both measures (Peak: F(1) = 4.80, p = .04, 1-𝛽 = .56; AUC:  F(1) = 10.47, p < .01, 
1-𝛽 = .88). For peak flow, the difference in cough strength between cough 1 and cough 2 was 
greater for females than for males (males mean difference = –0.26 L/s; females main 
difference = 0.44 L/s). However, for AUC flow, for females there was a decrease in cough 
strength from cough 1 to cough 2, whereas for males there was an increase (male mean 
difference = 0.05 L; female mean difference = –0.06 L). There was also a significant 
interaction effect of type of cough and cough sequence for peak flow (F(1) = 6.28, p = .02, 1-
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𝛽 = .68). This demonstrated that there was a smaller difference in strength of weak coughs, 
between cough 1 and cough 2, than for strong coughs (mean difference weak = –0.23 L/s; 
mean difference strong = –0.47 L/s). There was also a significant interaction effect of type of 
VC and gender for AUC flow (F(1) = 10.64, p < .01, 1-𝛽 = .88). This revealed that the 
difference in weak and strong coughs was greater for females than for males (female mean 
difference = 0.18 L; male mean difference = 0.06 L). 
 
 
Figure 16. Mean peak flow for voluntary cough. 
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Figure 17. Mean AUC flow for voluntary cough. 
 
4.2.3 Acoustic  
The means and standard errors for peak and AUC acoustic are displayed in Figures 18 
and 19. There was a significant main effect of type of VC, strong or weak, for both measures 
(Peak: F(1) = 41.59, p < .01, 1-𝛽 = 1.00; AUC: F(1) = 58.98, p < .01, 1-𝛽 = 1.00). This 
demonstrates that strong coughs were objectively stronger than weak coughs (Peak: mean 
weak cough = 0.40 V, mean strong cough = 0.65 V p < .01; AUC: mean weak cough = 0.02 
V.s, mean strong cough = 0.05 V.s p < .01). There was also a significant main effect of cough 
sequence for AUC acoustic (F(1) = 8.77, p < .01, 1-𝛽 = .82), showing that the first cough was 
stronger than the second cough (mean 1st cough = 0.04 V.s, mean 2nd cough = 0.03 V.s, p < 
.01). There was a significant interaction of type of voluntary cough and cough sequence for 
AUC acoustic (F(1) = 16.76, p < .01, 1-𝛽 = .98). This result revealed a greater difference in 
strength between cough 1 and cough 2 for strong than for weak coughs (mean difference 
strong = –0.02 V.s; mean difference weak = –0.005 V.s).  
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Figure 18. Mean peak acoustic for voluntary cough. 
  
 
 
Figure 19. Mean AUC acoustic for voluntary cough. 
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 The means and standard deviations for all reflexive and voluntary coughs are also 
shown in Appendix 7 and the repeated measures ANOVA results are also shown in Appendix 
8.  
4.3 Reflexive Cough versus Voluntary Cough 
As discussed earlier, the label ‘dose 1’ was the first concentration of citric acid that 
triggered a C2 response in an individual, ‘dose 2’ was the second concentration of citric acid 
administered and ‘dose 3’ the third. Although there was no significant difference in the 
strength of response to the three doses, dose 3 was arbitrarily chosen for comparison with 
strong voluntary coughs. Paired t-tests comparing cough 1 and cough 2 at dose 3 with cough 
1 and cough 2 of the strong voluntary coughs revealed that, on average, participants’ strong 
VCs were significantly stronger than their RCs at the highest dose of citric acid (see Table 1 
for details of findings). 
 
Table 1. Differences between reflexive cough 1 and 2 at citric acid dose 3 with voluntary 
cough 1 and 2 for each outcome measure 
Measure Cough 
Number 
Mean 
Difference 
Standard 
Deviation 
Standard 
Error  
t (28) Sig. Cohen’s d 
Peak 
Pressure 
(mmHg) 
1st cough 
2nd cough 
-5.106 
-4.034 
3.846 
3.097 
0.714 
0.575 
-7.1 
-7.0 
.000 
.000 
1.33 
1.30 
AUC 
Pressure 
(mmHg.s) 
1st cough 
2nd cough 
-0.269 
-0.146 
0.135 
0.103 
0.025 
0.019 
-10.7 
-7.6 
.000 
.000 
1.99 
1.42 
Peak Flow 
(L/s) 
1st cough 
2nd cough 
-1.100 
-0.844 
0.780 
0.638 
0.145 
0.118 
-7.6 
-7.1 
.000 
.000 
1.41 
1.32 
AUC Flow 
(L) 
1st cough 
2nd cough 
-0.176 
-0.186 
0.149 
0.142 
0.028 
0.026 
-6.3 
-7.1 
.000 
.000 
1.18 
1.31 
Peak 
Acoustic 
(V) 
1st cough 
2nd cough 
-0.254 
-0.305 
0.300 
0.247 
0.056 
0.046 
-4.5 
-6.6 
.000 
.000 
.85 
1.23 
AUC 
Acoustic  
(V.s) 
1st cough 
2nd cough 
-0.041 
-0.028 
0.034 
0.028 
0.006 
0.005 
-6.5 
-5.5 
.000 
.000 
1.21 
1.00 
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4.4 Comparisons of Measures 
Bivariate correlations of the measures for reflexive and voluntary coughs are shown in 
Table 2. For both RC and VC conditions, the highest correlations are between peak and AUC 
of the same measures. With regards to different measures, the highest correlation for VC and 
RC is between AUC pressure and peak flow, and AUC pressure and AUC flow. Acoustic 
measures correlate poorly with all other measures for RC and VC. 
 
Table 2. Correlations between six measures for reflexive and voluntary cough. 
 Reflexive Cough Voluntary Cough 
 Pearson’s 
Correlation (r) 
Sig. Pearson’s 
Correlation (r) 
Sig 
Peak pressure vs AUC pressure .628 p < .01 .836 p < .01 
Peak pressure vs Peak flow .571 p < .01 .474 p < .01 
Peak pressure vs AUC flow .377 p < .01 .440 p < .01 
Peak pressure vs Peak acoustic .334 p < .01 .436 p < .01 
Peak pressure vs AUC acoustic .313 p < .01 .422 p < .01 
AUC pressure vs Peak flow .757 p < .01 .613 p < .01 
AUC pressure vs AUC flow .756 p < .01 .595 p < .01 
AUC pressure vs peak acoustic .265 p < .01 .420 p < .01 
AUC pressure vs AUC acoustic .351 p < .01 .559 p < .01 
Peak flow vs AUC flow .802 p < .01 .770 p < .01 
Peak flow vs peak acoustic .001 p = .99 .290 p < .01 
Peak flow vs AUC acoustic .026 p = .73  .288 p < .01 
AUC flow vs peak acoustic .099 p = .20 .447 p < .01 
AUC flow vs AUC acoustic .112 p = .14 .406 p < .01 
Peak acoustic vs AUC acoustic .812 p < .01 .694 p < .01 
 
4.5 Marker Placement Error 
Three coughs out of a total of 348 coughs from the 29 data sets had their start and/or 
end markers placed manually as automatic placement could not be applied when the rectified 
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acoustic waveform did not exceed the threshold. An additional eight coughs had their start 
and/or end markers manually adjusted as the automatic placement caused peak clipping of 
pressure and/or flow waveforms. These eight coughs were analysed using root mean square 
error (RMSE) analysis to investigate the differences between the results gained by the 
automatically placed markers and the manually placed markers (see Table 3 for results of 
pressure measures and Table 4 for results of flow measures). These results indicate that the 
difference in peak pressure and AUC pressure values between the modified and unmodified 
values is very small, 0.06 RMSE and 0.05 RMSE, respectively (with a value of 0 
representing perfect agreement in values). However, for the values for peak flow and AUC 
flow were much higher, with RMSE of 0.73 and 0.17 respectively. This indicates that 
incorrect placement of the markers has most effect on the flow measures. 
 
Table 3. RMSE for peak pressure and AUC pressure for each of the eight coughs 
Adjusted Cough Peak 
Pressure 
mmHg 
(automatic 
markers) 
Peak 
Pressure  
mmHg 
(manual 
markers) 
Peak 
Pressure 
Difference 
mmHg 
AUC 
Pressure  
mmHg.s 
(automatic 
markers) 
AUC 
Pressure  
mmHg.s 
(manual 
markers) 
AUC 
Pressure 
Difference 
mmHg.s 
1 0.977 0.977 0.000 0.027 0.077 0.049 
2 2.086 2.086 0.000 0.030 0.047 0.018 
3 0.929 1.104 0.175 0.014 0.061 0.047 
4 0.153 0.178 0.025 0.017 0.028 0.011 
5 2.289 2.289 0.000 0.007 0.077 0.069 
6 3.772 3.772 0.000 0.027 0.111 0.084 
7 3.512 3.512 0.000 0.042 0.098 0.056 
8 1.252 1.252 0.000 0.022 0.059 0.037 
       Root Mean Square Error 
 
0.062 
  
0.052 
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Table 4. RMSE for peak flow and AUC flow for each of the eight coughs 
Adjusted Cough Peak Flow  
L/s 
(automatic 
markers) 
Peak Flow  
L/s 
(manual 
markers) 
Peak Flow 
Difference 
L/s 
AUC Flow  
L 
(automatic 
markers) 
AUC Flow  
L 
(manual 
markers) 
AUC Flow 
Difference 
L 
1 0.902 0.942 0.040 0.047 0.092 0.045 
2 0.671 0.706 0.035 0.012 0.133 0.121 
3 0.459 0.459 0.000 0.015 0.093 0.078 
4 0.189 0.224 0.036 0.052 0.093 0.041 
5 0.385 1.427 1.042 0.001 0.263 0.262 
6 0.502 1.870 1.368 0.002 0.209 0.207 
7 1.050 2.093 1.043 0.006 0.278 0.272 
8 0.820 1.279 0.459 0.013 0.184 0.171 
       Root Mean Square Error 0.730 
  
0.173 
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 Discussion 
It is vital to develop objective measures of reflexive cough strength to identify 
patients at risk of aspiration pneumonia. This study investigated measures of pressure, 
airflow, and acoustics for clinical application for assessment of coughing strength. All 
outcome measures were sensitive to detecting differences in strength of cough; but neither 
peak amplitude or AUC were superior in quantifying strength. Based on effect sizes and 
correlation, peak flow and AUC pressure appear to provide the best sensitivity of 
measurement. Acoustic measures had significantly lower effect sizes and lower correlation 
with pressure and flow. There was a significant difference between strength of VC and RC in 
healthy individuals, which highlights that assessment of VC does not provide accurate 
information about the function of RC. Therefore, assessment of an individual’s ability to 
protect their airway from aspiration must be made directly from assessment of RC. 
Furthermore, there was no dose-response for suppressed RC strength. However, there was a 
cough sequence effect for both VC and RC, with second coughs being weaker than the first.  
This research is unique in investigating cough strength in suppressed RC. The absence 
of dose-response conflicts with previous research examining cough strength in natural RC. 
This generates many questions regarding the differences between natural and suppressed RC 
and which will provide the most accurate information about cough effectiveness. 
5.1 Reflexive Cough 
It was hypothesized that as the dose of citric acid increased there would be a 
corresponding increase in strength of cough response. This hypothesis was based on previous 
research that found positive dose-response relationships when investigating natural cough 
testing with increasing doses of tussigenic agent (Cox et al., 1984; Fontana et al., 1997; Vovk 
et al., 2007). However, our results strongly indicated that there was no significant difference 
in the magnitude of cough response to different doses of citric acid. This outcome might be 
explained by the protocol of assessing suppressed cough rather than natural cough. It is 
postulated that suppressed cough is a closer approximation to true reflexive cough with no 
cortical involvement, as the individual can no longer voluntarily control their response to 
citric acid (Monroe et al., 2014). However, these findings suggest that although the sensitivity 
of suppressed coughing is truly reflexive, the individual may retain cortical control of the 
strength of true reflexive coughing and that in trying not to cough, strength is stifled. 
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Observations during data collection suggest that this may be true; most participants’ RCs 
were perceptually considered as weak to the investigator. Additionally, once the nebulizer 
was switched off and the participant was aware that the test was finished, and it was no 
longer necessary to suppress coughing, the perceptual strength of coughing subjectively 
increased. Anecdotally, it appeared that once the nebulizer was switched off, both the peak 
and duration of coughs increased. Conversely, it could be argued that these subsequent 
coughs, after stimulus is removed, are not true RCs and cortical control of coughing has been 
re-established.  
An alternative hypothesis for the lack of effect of dose on strength of coughing in 
suppressed CRT, is that in a true RC the strength elicited is an all-or-nothing response that is 
not dependent upon stimulus dose. The dose-effect observed in natural CRT could be 
explained by cortical augmentation of the all-or-nothing reflexive response. This would mean 
that any threat to the airway, whether a small amount of water or a large solid bolus, would 
result in the same strength of coughing in order to protect and clear the airway. Another 
explanation could be that, rather than any true RC being an all-or-nothing response, it is the 
true RC stimulated by citric acid that produces this standard response. Lasserson et al. (2006) 
emphasized that a tussigenic agent does not identically replicate an aspiration event. 
Therefore, cough responses in this study may not present the equivalent of a true cough 
response to aspiration. Pitts et al. (2014) demonstrated that coughing strength in cats is 
greater when the risk of aspiration is larger. This implies that although no dose effect of citric 
to coughing strength was identified, there is potential for the existence of a dose effect with 
actual aspiration.  
No hypothesis was made regarding any cough sequence effect (1st or 2nd cough in a 
sequence) on strength of individual coughs. However, there was a main effect of cough 
sequence with all outcome measures, with the second cough in the sequence being weaker 
than the first. This finding is consistent with other research that has shown that strength of 
coughing decreases over the course of a cough sequence (Fontana & Widdicombe, 2007; 
Lasserson et al., 2006; Vovk et al., 2007). This is likely due to decreasing lung volume as air 
is expelled during each cough, leading to less volume to contribute to subsequent coughs. 
This decreased lung volume also results in decreased expiratory muscle length which leads to 
reduced muscle force and consequently decreased airflow velocity (Vovk et al., 2007). 
Although it might be assumed that these weaker coughs are less effective in clearing the 
airway, it has been hypothesized that there is greater compression in the distal and smaller 
airways which results in greater linear velocity enabling clearance of substances from the 
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smaller air passages (Young et al., 1987). However, this clearance of the smaller airways is 
less important with regards to aspiration, where the key factor is prevention of entry and 
immediate expectoration from the upper, larger airways. Therefore, it is hypothesized that it 
is the first cough in a sequence that is key in airway protection and clearance of aspirate. 
5.2 Voluntary Cough 
The finding that volitionally produced strong coughs were indeed objectively stronger 
than volitionally produced weak coughs demonstrates that these outcome measures are 
sensitive to provide a relative measure of strength of coughing, as hypothesized. As with 
reflexive coughs, second coughs were found to be weaker than first coughs for measures of 
peak pressure, AUC pressure, peak flow, and AUC acoustic. This similar finding is to be 
expected, as the amount of residual air left in the lungs decreases with subsequent coughs 
(Vovk et al., 2007).  
Measures of peak pressure, peak flow, and AUC flow revealed variable relationships 
between cough sequence and gender. In particular, AUC flow unexpectedly revealed that in 
males the second cough is stronger than the first. The differences observed between genders 
with each measure highlight the variability of the outcome measures. It is suspected that there 
is greater error in AUC flow measures, compared to other outcomes, due to clipping of the 
waveform secondary to start and end marker placement (see section 5.5 for further discussion 
of this). This clipping of waveforms may have resulted in this irregular finding, and it could 
be concluded that the flow waveform start and end markers should be placed individually to 
minimize error. Additionally, it emphasizes the necessity for further research investigating 
effectiveness of coughing to aspiration so that the best outcome measure can be selected.  
Some of our measures, peak pressure, AUC pressure, peak flow, and AUC acoustic, 
demonstrated a larger decrease in strength between cough 1 and 2 for strong coughs than for 
weak coughs. This is likely due to a greater volume of air required to produce strong coughs 
than for weak coughs, resulting in less residual lung volume for the second cough. 
The relationship between type of cough and gender with AUC flow reveals a greater 
difference in strength between weak and strong coughs for females than in males. This 
relationship is only observed in one of the six outcome measures suggesting that this may be 
an anomaly. Again, this may be due to suspected inaccuracies in AUC flow measures, and 
this requires further investigation.  
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5.3 Reflexive Cough versus Voluntary Cough 
The finding that strong VCs are stronger than RCs is similar to results revealed by 
Lasserson et al. (2006), who showed that sEMG measures of respiratory muscle activity were 
greater for VC than for RC stimulated by tartaric acid. They hypothesized that this may be 
due to smaller lung volumes for RC compared to VC, where there is usually inspiration 
before the cough. It has already been suggested that reflexive airway protection status should 
not be determined from the assessment of VC (Addington et al., 2008; Stephens et al., 2003). 
The rationale for this is that RC is more complex and physiologically different than VC. 
Furthermore, VC is predominantly cortically controlled whereas RC is controlled by the 
rostral and caudal medulla (Mazzone et al., 2011). This implies that neurological impairment 
could result in very different outcomes for VC versus RC as shown by Fontana et al. (1998) 
who found that RC was more impaired than VC in patients with Parkinson’s disease. Our 
research further supports this, as VC strength is likely to be much stronger than a RC. 
Therefore, determining that VC is strong does not signify that RC will be strong enough to be 
effective. 
5.4 Outcome Measures 
A key intent of this study was to identify a salient measure of cough strength that 
could be easily implemented in clinical practice. All measures were sensitive to cough 
strength, but measures of AUC pressure and peak flow exhibited the largest effect sizes and 
strongest correlations indicating they have the best potential for clinical application. The 
results suggest that acoustic measures, using the methodology of a microphone attached to a 
stethoscope, may be less accurate and sensitive than pressure and flow measures. This is 
unfortunate, as acoustic measures are likely to be less expensive and more clinically practical 
compared to pressure and flow. Nonetheless, it is clear that further work is needed in order to 
verify the sensitivity and specificity of these measures to identify coughing that is ineffective 
in clearing aspirate.   
5.5 Error in Marker Placements 
By modifying the marker placement, where pressure or flow peaks were clipped, it 
was possible to ensure that peak amplitudes for all measures were 100% accurate. Had these 
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markers not been moved, substantially different results for those coughs would have been 
observed, particularly for peak flow, which was most affected by clipping. 
It was important to look at AUC as well as peak measures as it provides a measure of 
strength of the entire duration of the cough rather than just one point within the cough. 
Lasserson et al. (2006) described AUC as the ‘total activity’ of a cough. This measure is 
important as some coughs are of greater duration than others and it may be that this increased 
duration of a cough is part of its strength and effectiveness in clearing (Addington et al., 
2008). These results do not identify any advantage of either AUC or peak in terms of 
measurement of strength. However, this could be further investigated by studying the 
effectiveness of cough response to aspiration using the same outcome measures. The RMSE 
analysis shows that for both pressure and flow, the biggest error for the eight modified 
coughs was for peak flow. It is likely that there was some error in AUC measures of flow for 
all coughs analysed, this is due to flow measures tending to finish later than either pressure or 
acoustic measures, resulting in clipping of the end of waveforms. However, the automatic 
maker systems should have ensured relatively consistent error between coughs and between 
participants. 
5.6 Exclusions 
Recent research by Monroe et al. (2014) evaluated natural cough threshold and 
suppressed cough threshold in healthy individuals. They found that 65% of participants 
triggered a suppressed C2 response by a citric acid dose of 0.8 Mol/L. In order for 
participants in this study to be included they had to produce a suppressed C2 at a consecutive 
three doses, thus requiring a response at or before doses of 0.8 Mol/L, 1.2 Mol/L, and 1.8 
Mol/L. Therefore, on the basis of this normative data, it is expected that approximately 35% 
of participants would not produce a C2 response at 0.8 Mol/L, and thus would be excluded 
from analysis. These research findings align with those of Monroe et al. (2014). 
When excluding participants who did not produce a C2 response, this decision was 
made on the basis of the airflow data. Where inhalation between cough 1 and 2 was observed 
to occur on the airflow waveform, the cough was marked as a fail. It is interesting to note that 
clinical decisions are made on a perceptual basis as to whether or not inhalation occurs 
between cough 1 and 2. It is likely some participants who were excluded on the basis of 
airflow data would have been included from perceptual judgement of C2 response. 
MEASURING VOLUNTARY AND REFLEXIVE COUGH STRENGTH IN HEALTHY INDIVIDUALS  54 
 
 
 
5.7 Limitations 
The protocol used a non-airtight facemask, the benefits of this were that these masks 
are cheap, accessible, and already being used in clinical settings. However, the fact that the 
mask was not airtight, resulting in air escape around the edges of the mask, means that flow 
and pressure measurements are not absolute measures of coughing strength, but relative 
measures. However, what is clinically required is a consistent, relative measure of RC 
strength that will allow judgement of effectiveness of coughing using consumable materials 
that are readily available and inexpensive. The face-mask set-up utilized in this study 
demonstrates the potential to provide this. 
Pressure and flow measures were taken simultaneously, which will have resulted in a 
decreased magnitude of pressure values secondary to air escape via the flowhead. However, 
this set-up was important, as it allowed us to directly compare all outcome measures for the 
same coughs. As discussed above, it provided a relative measure of pressure adequate for a 
comparative assessment of coughing strength.  
Consistent placement of the stethoscope for acoustic measures was difficult due to 
small anatomical differences between participants; for some people, despite manipulation of 
placement, the microphone detected carotid pulse which may have affected the outcomes. 
Furthermore, the use of a stethoscope connected to a microphone, rather than just using a 
microphone, means that the majority of the sound detected will have been internal sounds, 
whereas a microphone predominantly detects external sounds. The measurement of internal 
sounds is likely to be more affected by inter-participant variability due to anatomical 
differences. It would be useful in future research to trial the use of a microphone taped to the 
suprasternal notch or held at a set distance from the facemask in order to increase inter-
participant reliability.  
As discussed previously, there may be some clipping of waveforms, particularly for 
pressure and flow, as a consequence of the methodology utilized for marker placement. 
Unfortunately, any method for placement of markers which chooses a start and end of a 
cough for all waveforms would inevitably result in clipping of some of the waveforms, as the 
coughs do not begin and end in precisely the same place for each outcome measure. 
However, the benefits of choosing a start and end placement for all measures is that they can 
be directly compared. The benefit of an automatic placement system also ensures that there 
will be consistency in the clipping of AUC measures and that the study is repeatable.  
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5.8 Clinical Implications 
This study confirms research advocating the importance of assessing strength of RC, 
rather than VC, in the dysphagic population.  The development of a method to objectively 
measure strength of RC is vital to enable clinical judgement regarding the effectiveness of 
RC in protecting and clearing the airway. Measurements of pressure, flow, and acoustics all 
show promise for such objective measurements. 
There is no dose-response to cough strength for suppressed cough, suggesting that 
perceptual or objective measures of this could be obtained from any dose of citric acid to 
indicate adequacy of airway protection. However, if coughing strength is cortically 
controlled, strength of suppressed cough may not accurately represent the reflexive cough 
response to aspiration. Based on these findings, it is recommended that perceptual 
judgements of coughing strength should be made with great caution. These findings suggest 
that most healthy individuals would perceptually present with a weak suppressed RC and, 
thus, fail CRT. Therefore, further investigation into strength of both natural and suppressed 
RC is required. Additionally, when making perceptual judgements of coughing strength, 
given that the second cough is usually weaker than the first, it would also be wise for 
clinicians to make their judgement of coughing strength on the first rather than any 
subsequent coughs.  
5.9 Future Directions 
It would be useful to repeat this study with the addition of measurement of natural 
cough reflex using the same equipment set-up. This would provide more information about 
whether or not a dose effect is seen in natural CRT. The lack of dose effect observed in 
suppressed CRT could be due to cortical inhibition of strength of coughing, or due to RC 
being an all-or-nothing response, or it could be a result of citric acid stimulus not providing a 
true simulation of aspiration. In order to further elucidate this, the following studies are 
proposed: 
1. Investigation of natural and suppressed RC strength to aspiration would provide 
information regarding cortical inhibition of strength of coughing in suppressed CRT. 
This could be achieved utilizing this study’s face-mask set-up whilst injecting different 
volumes of water onto the vocal cords to simulate aspiration in healthy individuals. This 
would also clarify whether an RC triggered by aspirate is an all-or nothing response, or 
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whether it increases with greater threat to the airway. It should also enable the 
establishment of a cough reflex strength threshold which could be used to identify 
patients who have ineffective coughing. Finally, it would help to clarify which measure 
of strength most accurately identifies ineffective coughing.  
2. Validation of this cough reflex strength test could also be carried out by comparing the 
findings of the test with VFSS findings to analyse which measures correspond best with 
ineffective and effective coughing. This would also enable the establishment of a 
reflexive cough strength threshold. 
3. Comparison of perceptual judgements of strength and presence or absence of a C2 
response against these objective measures of suppressed cough strength would be useful 
to further explore observations made that suppressed cough is perceptually weak. It is 
hypothesized that most of these reflexive coughs will be rated as being weak. 
4.  It would be useful for further research, like that of Mazzone, McGovern, Koo, & Farrell 
(2009), to investigate the neurological control of suppressed and natural cough to 
evaluate whether there is a difference and whether there is evidence of cortical 
involvement in suppressed coughing which might indicate cortical control of strength of 
RC. 
These studies would provide the information required to determine if it is possible to 
accurately measure effectiveness of RC strength and whether or not this should be done from 
natural or suppressed cough. They will also enable further evaluation of the sensitivity of the 
different outcome measures and verification of whether peak amplitude or AUC provides a 
better measure of effective cough strength and whether any measures are more accurate or 
consistent than the others. 
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 Conclusion 
This research is the first step in developing a test that will enable objective 
measurement of the strength of RC and establish a threshold of effective RC. It has 
demonstrated that pressure, flow, and acoustic measures are all sensitive to measurement of 
strength of coughing. However, acoustic measures tend to show lower effect sizes and 
correlate less with other measures, and peak flow and AUC pressure show the most promise 
for assessment of cough strength, with the highest effect sizes and correlation. Subsequent 
coughs in a cough sequence are likely to be lower in strength than the first. Furthermore, 
there is no effect of increasing citric acid dose on suppressed reflexive cough strength, which 
highlights the need for further study into both suppressed and natural CRT using this 
methodology.  
Further research is needed to refine the test and establish a threshold for effective 
cough strength, which will then enable more precise identification and management of 
patients who are at risk of aspiration pneumonia.  
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Appendix 2 –  
Information Sheet  
 
Swallowing Rehabilitation Research Lab & EATS Clinic 
The University of Canterbury 
Rose Centre for Stroke Recovery and Research at St George’s Medical 
Centre 
Leinster Chambers, Level One 
Private Bag 4737 
249 Papanui Road 
Christchurch 8140 
New Zealand 
 
Telephone: +64 3 364 2307 
Email: claire.mills@pg.canterbury.ac.nz 
  
01.05.2015 
 
Measuring Cough Strength in Healthy Individuals using Cough Reflex 
Testing 
 
I am conducting research as part of my Master’s Thesis at the University of Canterbury. The 
purpose of my research is to develop a method for us to quickly and easily measure the 
strength of a person’s cough. The aimis for this information to eventually be used with 
patients in hospitals, where it is hoped that measure of their cough strength will help us to 
identify people who are at risk of chest infections. 
 
You will participate in a cough test, which involves breathing in a variety of mists through a 
face mask. These mists may, or may not, make you cough. The facemask has sensors that will 
measure and record the strength of your cough. With your consent, a video-recording will be 
made of the test. This recording will be used for determining the results of the study and/or 
teaching. If you choose to consent to video-recording for results only, then the video 
recording will be deleted on conclusion of the study.  
 
During the cough test you may experience some irritation in your throat. There are no other 
risks associated with this procedure and these mists have been widely used to stimulate cough 
production with no serious side-effects. The procedure itself should take 60 minutes in total, 
with no further follow-up required. 
 
Participation is voluntary and you have the right to withdraw at any stage without providing 
reason. If you withdraw, none of your information will be retained. The results of the project 
may be published, but no information that will personally identify you will be used. A 
Master’s thesis is a public document and will be available through the UC Library. You may 
receive a copy of the project results by contacting me at the conclusion of the project.  
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To ensure confidentiality, all information relating to you will be given a code number and 
your consent form will be kept in a locked filing cabinet, accessible only to staff of the 
Swallowing Rehabilitation Research Laboratory. Video-recordings will be password 
protected. All identifiable information about you will be destroyed after 10 years.  
 
I will be carrying out the project, as a requirement for my Master’s Thesis, under the 
supervision of Associate Professor Maggie-Lee Huckabee and Professor Richard Jones, who 
can be contacted at maggie-lee.huckabee@canterbury.ac.nz and 
richard.jones@canterbury.ac.nz. They will be pleased to discuss any concerns you may have 
about participation in the project. 
 
This project has been reviewed and approved by the University of Canterbury Human Ethics 
Committee, and participants should address any complaints to The Chair, Human Ethics 
Committee, University of Canterbury, Private Bag 4800, Christchurch (human-
ethics@canterbury.ac.nz).  
 
If you agree to participate in the study, you are asked to complete the consent form and return 
it to me.  
 
Thank you for your consideration. 
Kind Regards 
 
 
 
 
Claire Mills 
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Appendix 3 –  
Consent Form  
Swallowing Rehabilitation Research Lab & EATS Clinic 
The University of Canterbury 
Rose Centre for Stroke Recovery and Research at St George’s Medical Centre 
Leinster Chambers, Level One 
Private Bag 4737  
249 Papanui Road 
Christchurch 8140 
New Zealand 
Telephone: +64 3 364 2307 
Email: claire.mills@pg.canterbury.ac.nz 
  
01.05.2015 
 
 
Measuring Cough Strength in Healthy Individuals using Cough Reflex 
Testing 
                                    Please Initial Box 
1. I confirm that I do not have any of the following: reflux, respiratory condition, 
neurological condition, swallowing difficulties 
2. I confirm that I have not smoked in the past year 
3. I confirm that I am not currently taking steroids or opiates and have not taken 
codeine-based analgesia in the last 24 hours 
4. I confirm that I have read and understood the description of the above-named project 
and have had the opportunity to ask questions. On this basis I agree to participate as 
a subject in the project, and I consent to publication of the results of the project with 
the understanding that my anonymity will be preserved.  
5. I consent to video-recording of my cough test and for this to be used for: 
a. Research purposes e.g. results of the cough test 
b. Teaching purposes e.g. undergraduates, conference presentations 
6. I understand that participation is voluntary and I may withdraw at any time, 
including withdrawal of any information I have provided should this remain 
practically achievable. 
7. I understand that the project has been reviewed and approved by the University of 
Canterbury Human Ethics Committee 
8. I would like to receive a copy of the summary of results on conclusion of the project 
By signing below, I agree to participate in this research project.  
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Name:______________________________________________________________ 
Signature:___________________________________________________________ 
Date:_______________________________________________________________ 
Please return the form to me when attending the clinic for participation in the study. 
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Appendix 4 –  
Format for Counter-balancing of Presentation of Voluntary and Reflexive 
Coughs 
Each participant was given a code with a number relating to the order they were seen, starting 
with 1, and a letter relating to the presentation of stimulus.  
 
The letters represented the following presentation of stimulus:  
A = VCB1, VCB2, VCW1, VCW2, CA 
B = VCB2, VCB1, VCW2, VCW1, CA 
C = VCW1, VCW2, VCB1, VCB2, CA 
D = VCW2, VCW1, VCB2, VCB1, CA 
E = CA, VCB1, VCB2, VCW1, VCW2 
F = CA, VCB2, VCB1, VCW2, VCW1 
G = CA, VCW1, VCW2, VCB1, VCB2 
H = CA, VCW2, VCW1, VCB2, VCB1 
I = VCB1, VCB2, CA, VCW1, VCW2 
J = VCB2, VCB1, CA, VCW2, VCW1 
K = VCW1, VCW2, CA, VCB1, VCB2 
L =VCW2, VCW1, CA, VCB2, VCB1 
 
Abbreviations: 
VCB1 = 1 strong voluntary cough 
VCB2 = 2 strong voluntary coughs 
VCW1 = 1 weak voluntary cough 
VCW2 = 2 weak voluntary coughs 
CA = Reflexive coughs (always presented in increasing order of dose) 
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Appendix 5 –  
Example Data Form 
Data Collection form for A - VCB1, VCB2, VCW1, VCW2, CA 
 
Task Detail Tick when 
complete 
Discuss information sheet   
Discuss and sign the consent form   
Take DOB of participant   
Get signature for petrol voucher   
Attach stethoscope to neck   
Secure face mask   
Set-up video-recording   
Get a strong cough to check audio volume   
Remind:  
- try not to touch the mask once it’s in place 
- the mist will only be applied for up to 15 seconds 
- once I’ve stopped the mist you can take the mask off but try to wait until then if possible 
- if you want to stop at any point just say 
- if you want a glass of water please ask 
  
Start AD lab and video- recording   
Turn Nebulizer on VolCough – 1 strong Tag VCB1  
60 seconds rest   
Turn Nebulizer on VolCough – 2 strong on one breath Tag VCB2  
60 seconds rest   
Turn Nebulizer on VolCough – 1 weak Tag VCW1  
60 seconds rest   
Turn Nebulizer on VolCough – 2 weak on one breath  Tag VCW2  
60 seconds rest   
“Don’t hold your breath. Breathe in and out through mouth 
and if feel need to cough try to suppress it” 
  
Let them smell CA 1.2 from open container   
60 seconds rest   
Placebo (15 seconds) Tag P  
60 seconds rest   
CA0.4 (15 seconds) Tag CA0.4  
60 seconds rest   
Placebo (15 seconds) Tag P  
60 seconds rest   
CA0.8 (15 seconds) Tag CA0.8  
60 seconds rest   
Placebo (15 seconds) Tag P  
60 seconds rest   
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CA1.2 (15 seconds) Tag CA1.2  
60 seconds rest   
Placebo (15 seconds) Tag P  
60 seconds rest   
CA1.8 (15 seconds) Tag CA1.8  
Stop AD lab and audio and video recording   
Save recordings   
 
  
 
Appendix 6 –   
Table of Means and Standard Deviations for Reflexive and Voluntary Coughs 
Stimulus Cough 
Number 
Peak Pressure 
mmHg 
AUC Pressure 
mmHg.s 
Peak Flow 
L/s 
AUC Flow 
L 
Peak Acoustic 
V 
AUC Acoustic 
V.s 
  Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD 
Dose 1 of 
Citric acid 
1st 
2nd 
2.097 
1.680 
1.174 
0.932 
0.072 
0.047 
0.046 
0.028 
0.905 
0.570 
0.555 
0.371 
0.133 
0.085 
0.090 
0.062 
0.391 
0.357 
0.248 
0.264 
0.015 
0.012 
0.012 
0.011 
Dose 2 of 
Citric acid 
1st  
2nd 
2.300 
1.774 
1.522 
1.079 
0.077 
0.042 
0.048 
0.021 
0.869 
0.631 
0.546 
0.445 
0.132 
0.086 
0.077 
0.059 
0.381 
0.339 
0.269 
0.248 
0.017 
0.010 
0.019 
0.009 
Dose 3 of 
Citric acid 
1st  
2nd 
2.246 
1.942 
0.988 
1.296 
0.080 
0.048 
0.051 
0.028 
0.920 
0.664 
0.575 
0.519 
0.158 
0.106 
0.124 
0.089 
0.400 
0.311 
0.292 
0.273 
0.017 
0.011 
0.017 
0.012 
2 weak 
voluntary 
coughs 
1st  
2nd 
1.849 
1.672 
1.178 
1.112 
0.119 
0.085 
0.068 
0.056 
1.347 
1.089 
0.661 
0.603 
0.176 
0.172 
0.091 
0.118 
0.369 
0.362 
0.279 
0.275 
0.013 
0.017 
0.015 
0.018 
2 strong 
voluntary 
coughs 
1st  
2nd 
7.352 
5.976 
3.798 
2.885 
0.349 
0.194 
0.132 
0.097 
2.020 
1.508 
0.734 
0.568 
0.334 
0.292 
0.133 
0.108 
0.654 
0.616 
0.129 
0.172 
0.057 
0.040 
0.035 
0.027 
 
 
 
 
 
  
 
Appendix 7 –  
Table of Repeated-Measures ANOVA Results for Voluntary and Reflexive Coughs 
 
Effect  Cough Sequence Dose Type of cough Cough sequence * gender Type of cough * cough sequence Type of cough * gender 
  RC VC RC VC VC VC VC 
P
ea
k
 
P
re
ss
u
re
 F 11.877 16.482 0.435 57.726 11.303 27.038 0.239 
p-value .002 <.001 .650 <.001 .002 <.001 .629 
Effect size 0.078 <.001 - 0.012 - <.001 - 
Power .913 .975 .117 1.000 .900 .999 .076 
A
U
C
 
P
re
ss
u
re
 F 30.759 59.465 0.121 54.089 0.011 27.038 0.005 
p-value <.001 <.001 .862 <.001 .916 <.001 .943 
Effect size 1.361 3.401 - 23.110 - 1.040 - 
Power 1.000 1.000 .067 1.000 .051 .999 .051 
P
ea
k
 
F
lo
w
 
F 33.251 66.774 0.050 20.544 4.801 6.275 2.714 
p-value <.001 <.001 .952 <.001 .037 .019 .111 
Effect size 0.706 0.166 - 1.321 - -0.011 - 
Power 1.000 1.000 .057 .992 .561 .676 .355 
A
U
C
 
F
lo
w
 
F 10.649 0.049 2.369 44.402 10.465 1.693 10.643 
p-value .003 .827 .103 <.001 .003 .204 .003 
Effect size 0.376 - - 33.472 - - - 
Power .882 .055 .459 1.000 .877 .241 .882 
P
ea
k
 
A
co
u
st
ic
 F 4.511 1.043 0.560 41.585 0.116 0.189 1.008 
p-value .043 .316 .925 <.001 .736 .667 .324 
Effect size 0.018 - - 8.385 - - - 
Power .535 .167 .058 1.000 .062 .070 .162 
A
U
C
 
A
co
u
st
ic
 F 10.937 8.771 0.560 58.983 .642 
No effect 
16.755 2.457 
p-value .003 .006 .926 <.001 .430 <.001 .129 
Effect size 0.482 -0.244 - 2.719 - 0.637 - 
Power .890 .815 0.058 1.000 .121 .976 .327 
 
